0001213900-21-059027.txt : 20211115 0001213900-21-059027.hdr.sgml : 20211115 20211115093851 ACCESSION NUMBER: 0001213900-21-059027 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FOUNTAIN HEALTHY AGING, INC. CENTRAL INDEX KEY: 0001309251 STANDARD INDUSTRIAL CLASSIFICATION: TRANSPORTATION SERVICES [4700] IRS NUMBER: 861098668 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-123774 FILM NUMBER: 211406979 BUSINESS ADDRESS: STREET 1: 2764 LAKE SAHARA DRIVE STREET 2: SUITE 111 CITY: LAS VEGAS STATE: NV ZIP: 89117 BUSINESS PHONE: 604-331-1459 MAIL ADDRESS: STREET 1: 2764 LAKE SAHARA DRIVE STREET 2: SUITE 111 CITY: LAS VEGAS STATE: NV ZIP: 89117 FORMER COMPANY: FORMER CONFORMED NAME: IMMUREBOOST, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: eSavingsStore.com, Inc. DATE OF NAME CHANGE: 20060821 FORMER COMPANY: FORMER CONFORMED NAME: Celtic Cross Ltd. DATE OF NAME CHANGE: 20041119 10-Q 1 f10q0921_fountainhealthy.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 333-123774

Fountain Healthy Aging, Inc.

(Exact name of registrant as specified in its charter)

Nevada		86-1098668
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

Room 601, Bldg. E,

No. 1, Huabao Fubao China Street,
Futian District

Shenzhen City, Guangdong Province

518000

(Address of principal executive offices)

(Zip Code)

+86 185 6676 1769

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		N/A		N/A

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registration statement was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date: 609,316,077 shares as of November 12, 2021.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION

Item 1.	Financial Statements	F-1

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	11

Item 4.	Controls and Procedures	11

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	12

Item 1A.	Risk Factors	12

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	12

Item 3.	Defaults Upon Senior Securities	12

Item 4.	Mine Safety Disclosures	12

Item 5.	Other Information	12

Item 6.	Exhibits	12

SIGNATURES		13

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

FOUNTAIN HEALTHY AGING, INC.

TABLE OF CONTENTS

		Pages
Condensed Consolidated Balance sheets as of September 30, 2021 (Unaudited) and December 31, 2020 (Audited)		F-2
Condensed Consolidated Statements of Loss and Comprehensive Loss for the nine months ended September 30, 2021 and 2020 (Unaudited)		F-3
Condensed Consolidated Statements of Changes in Equity (Deficit) for the nine months ended September 30, 2021 and 2020 (Unaudited)		F-4
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020 (Unaudited)		F-5
Notes to Condensed Consolidated Financial Statements for the nine months ended September 30, 2021 (Unaudited)		F-6-F-14

F-1

FOUNTAIN HEALTHY AGING, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In U.S. Dollars, except share data or otherwise stated)

AS OF SEPTEMBER 30, 2021 (UNAUDITED) AND DECEMBER 31, 2020 (AUDITED)

	September 30, 2021			December 31, 2020
	US$			US$
ASSETS
Current assets:
Cash and cash equivalents		1,220,174			61,517
Accounts receivable		2,485,330			-
Other receivables		179,466			101,432
Inventory		11,794,031			66,037
Prepayment		12,558			133,646
Advance to suppliers		11,556,402			-
Amount due from related parties		52,762			142,450
Total current assets		27,300,723			505,082

Non-current assets:
Leasehold improvements and equipment, net		413,363			87,333
Intangible assets		78,594			-
Operating lease right-of-use assets		159,532			383,203
Deferred tax assets		108,633			-
Total non-current assets		760,122			470,536
Total assets		28,060,845			975,618

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable		456,339			134,842
Income tax payables		2,391,384			31,774
Other payables and accruals		898,518			336,604
Deferred revenue		259,260			27,648
Amount due to related parties		79,491			1,097,152
Current operating lease liabilities		139,483			319,697
Total current liabilities		4,224,475			1,947,717

Non-current liabilities:
Non-current operating lease liabilities		20,049			63,506
Total non-current liabilities		20,049			63,506
Total liabilities		4,244,524			2,011,223

COMMITMENTS AND CONTINGENCIES

EQUITY (DEFICIT)
Share capital (750,000,000 shares of Common Stock, par value $0.00001 per share, authorized, of which 609,316,077 and 600,034,500 shares are issued and outstanding as of September 30, 2021 and December 31, 2020, respectively; and 100,000,000 shares of Series A Preferred Stock, par value $0.00001 per share, of which all 100,000,000 shares are issued and outstanding)
Series A Preferred Stock		1,000			1,000
Common Stock		6,093			6,000
Additional paid in capital		10,215,427			(15,146	)
Foreign currency translation reserves		(134,240	)		(54,091	)
Retained earnings (Accumulated deficit)		13,728,041			(973,368	)
Total equity (deficit)		23,816,321			(1,035,605	)
Total liabilities and equity		28,060,845			975,618

The accompanying notes are an integral part of the financial statements.

F-2

FOUNTAIN HEALTHY AGING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS

(In U.S. Dollars, except share data or otherwise stated)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (UNAUDITED)

	Three months ended September 30,						Nine months ended September 30,
	2021			2020			2021			2020
	(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)
	US$			US$			US$			US$
Revenue		15,045,396			459,795			28,915,041			927,889
Cost of revenue		(4,430,256	)		(86,243	)		(8,141,174	)		(155,541	)
Gross profit		10,615,140			373,552			20,773,867			772,348

Selling and marketing expenses		(219,006	)		(24,943	)		(392,350	)		(84,087	)
General and administrative expense		(525,927	)		(700,095	)		(1,087,491	)		(1,279,879	)
Total operating expenses		(744,933	)		(725,038	)		(1,479,841	)		(1,363,966	)
Operating profit (loss)		9,870,207			(351,486	)		19,294,026			(591,618	)

Other income, net		(2,446	)		51			3,524			1,271
Profit (Loss) before income taxes		9,867,761			(351,435	)		19,297,550			(590,347	)

Income taxes		(2,548,699	)		-			(4,690,805	)		-
Net profit (loss) for the period		7,319,062			(351,435	)		14,606,745			(590,347	)

Foreign currency translation differences		58,282			(31,511	)		(80,149	)		(25,516	)
Total comprehensive income (loss) for the period		7,377,344			(382,946	)		14,526,596			(615,863	)

Earnings per share:
- Basic		0.012			0.000			0.024			0.001
- Diluted		0.012			0.000			0.024			0.001

Weighted average number of shares used in computation:
- Basic		604,574,402			600,034,500			601,564,430			600,034,500
- Diluted		604,574,402			600,034,500			601,564,430			600,034,500

The accompanying notes are an integral part of the financial statements.

F-3

FOUNTAIN HEALTHY AGING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

(In U.S. Dollars, except share data or otherwise stated)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (UNAUDITED)

	Share Capital							Foreign			(Accumulated Deficit) Retain Earnings
	Series A preferred Stock		Common Stock		Additional paid in Capital			Currency Translation Reserve			Unrestricted			Statutory Reserve		Total Equity (Deficit)
	US$		US$		US$			US$			US$			US$		US$
Balance at January 1, 2020 (Audited)		1,000		6,000		(15,146	)		4,547			(352,392	)		6,894		(349,097	)
Loss for the period		-				-			-			(590,347	)		-		(590,347	)
Other comprehensive income		-				-			(25,516	)		-			-		(25,516	)
Balance at September 30, 2020 (Unaudited)		1,000		6,000		(15,146	)		(20,969	)		(942,739	)		6,894		(964,960	)

Balance at January 1, 2021 (Audited)		1,000		6,000		(15,146	)		(54,091	)		(980,262	)		6,894		(1,035,605	)
Business combination under common control		-		93		10,230,573			-			-			94,664		10,325,330
Profit for the period		-				-			-			14,606,745			-		14,606,745
Other comprehensive loss		-				-			(80,149	)		-			-		(80,149	)
Balance at September 30, 2021 (Unaudited)		1,000		6,093		10,215,427			(134,240	)		13,626,483			101,558		23,816,321

The accompanying notes are an integral part of the financial statements.

F-4

FOUNTAIN HEALTHY AGING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In U.S. Dollars, except share data or otherwise stated)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (UNAUDITED)

	2021			2020
	US$			US$
Cash flows from operating activities:
Net profit (loss)		14,606,745			(590,347	)

Adjustments for:
Depreciation and amortization		70,255			17,976
Impairment of intangible assets		-			76,199
Changes in:
Accounts receivable		(1,205,866	)		(133,260	)
Other receivables and prepayment		75,544			(158,153	)
Inventory		(7,092,718	)		9,225
Advance to suppliers		(3,953,044	)		79,544
Deferred tax assets		(108,215	)		-
Accounts payable, other payables and accruals		(1,029,640	)		171,314
Income tax payables		939,691			-
Deferred revenue		(71,027	)		(202,827	)
Amount due from/to related parties		(959,679	)		805,152
Net cash provided by operating activities		1,272,046			74,823

Cash flows from investing activities:
Additions to leasehold improvements and equipment		(104,739	)		-
Additions to intangible assets		(61,809	)		-
Cash acquired from business combination		48,689			-
Net cash used in investing activities		(117,859	)		-

Effect of exchange rate changes on cash and cash equivalents		4,470			2,836

Net increase in cash and cash equivalents		1,158,657			77,659
Cash and cash equivalents at the beginning of year		61,517			23,046
Cash and cash equivalents at the end of the year		1,220,174			100,705

Supplemental disclosure of non-cash investing and financing activities:
Income tax paid		3,761,784			-

Right-of-use assets obtained in exchange for operating lease obligations		165,231			291,480

The accompanying notes are an integral part of the financial statements.

F-5

FOUNTAIN HEALTHY AGING, INC.

CONDENSED CONSOLIDATED NOTES TO THE FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 (UNAUDITED)

DESCRIPTION OF BUSINESS

Fountain Healthy Aging, Inc. and its subsidiaries (the “Company” or “FHAI”) are engaged in the business of wholesale distribution of “coffee tea” and wine products to retail partners and corporate customers, selling “coffee tea” and wine products to individual consumers and providing pre-opening assistance to retail partners to operate coffee and wine stores in the People’s Republic of China (“PRC” or “China”).

On June 2, 2021, FHAI’s wholly-owned subsidiary Shenzhen Wei Lian Jin Meng Electronic Commerce Limited (“Shenzhen Wei Lian”) entered into an equity transfer agreement with the owners (the “Sellers”) of Shenzhen Nainiang Wine Industrial Co., Ltd. (“Nainiang Wine”), under which Shenzhen Wei Lian agreed to acquire 99% ownership of Nainiang Wine in exchange for causing FHAI to issue shares of its common stock to the Sellers at a later date (the “PRC Transaction”). The PRC Transaction closed on June 3, 2021. Among the Sellers is Ms. Zhu Hong, who is the sole officer and director of FHAI and the majority shareholder of FHAI.

On August 16, 2021, FHAI entered into a Share Exchange Agreement with Nainiang Wine and the Sellers pursuant to which FHAI agreed to issue 9,281,577 shares of its common stock (the “Exchange Shares”) to the Sellers (the “US Transaction,” and together with the PRC Transaction, the “Nainiang Wine Transaction”). The US Transaction closed on August 16, 2021, and the Exchange Shares were issued to the Sellers. For more information about the Nainiang Wine Transaction, please refer to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 16, 2021.

BASIS OF PRESENTATION

In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. All significant intercompany transactions and balances are eliminated in consolidation. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.

The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the Securities and Exchange Commission (“SEC”) on April 15, 2021 (“2020 Form 10-K”).

F-6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a)

Use of estimates

The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ materially from those estimates.

There is no change on the accounting policies from the year ended December 31, 2020.

(b)

Revenue Recognition

The Company’s revenues primarily include Company sales, franchise fees and income and revenues from transactions with franchisees.

Product sales

Product sales represents the sale of “coffee tea” and wine products. Such revenue is recognized net of value-added taxes, upon delivery at such time that title passes to the customers.

Franchise fees and income

Franchise fees and income primarily include upfront franchise fees, such as initial fees, pre-opening assistance to operate wine stores, subsequent training provided to franchisees and renewal fees. The Company has determined that the services provided in exchange for upfront franchise fees are highly interrelated with the franchise rights. The franchise rights are accounted for as rights to access the Company’s symbolic intellectual property in accordance with ASC 606, and the Company recognizes upfront franchise fees received from a franchisee as revenue when performance obligations are satisfied in accordance with the franchise agreement or the renewal agreement. The franchise agreement term is typically 3 years.

Revenues from transactions with franchisees

Revenues from transactions with franchisees consist primarily of sales of wine products. The Company sells and delivers wine products to the franchisees. The performance obligations arising from such transactions are considered distinct from the franchise agreement as they are not highly dependent on the franchise agreement and the customer can benefit from the procurement service on its own. Revenue is recognized upon transfer of control over ordered items, generally upon delivery to the franchisees.

In determining the amount and timing of revenue from contracts with customers, the Company exercises significant judgment with respect to collectability of the amount; however, the timing of recognition does not require significant judgment, as it is based on either the franchise term or the date of product shipment, none of which require estimation.

The Company does not incur a significant amount of contract acquisition costs in conducting its franchising activities. The Company believes its franchising arrangements do not contain a significant financing component.

F-7

The Company’s revenue recognition policy is compliant with ASC 606, Revenue from Contracts with Customers, and revenue is recognized when a customer obtains control of promised goods and is recognized in an amount that reflects the consideration that the Company expects to receive in exchange for those goods. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount:

(i)

identification of the goods and services in the contract;

(ii)

determination of whether the goods and services are performance obligations, including whether they are distinct in the context of the contract;

(iii)

measurement of the transaction price, including the constraint on variable consideration;

(iv)

allocation of the transaction price to the performance obligations; and

(v)

recognition of revenue when (or as) the Company satisfies each performance obligation.

The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery or service being rendered.

For all reporting periods, the Company has not disclosed the value of unsatisfied performance obligations for all product revenue contracts with an original expected length of one year or less, which is an optional exemption that is permitted under the adopted rules.

(c)

Accounts Receivable

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable. The Company assesses the probability of collection from each customer at the outset of the arrangement based on a number of factors, including the customer’s payment history and its current creditworthiness. If in management’s judgment collection is not probable, the Company does not record revenue until the uncertainty is removed.

Management performs ongoing credit evaluations, and the Company maintains an allowance for potential credit losses based upon its loss history and its aging analysis. The allowance for doubtful accounts is the Company’s best estimate of the amount of credit losses in existing accounts receivable. Management reviews the allowance for doubtful accounts each reporting period based on a detailed analysis of trade receivables. In the analysis, management primarily considers the age of the customer’s receivable, and also considers the creditworthiness of the customer, the economic conditions of the customer’s industry, general economic conditions and trends, and the business relationship and history with its customers, among other factors. If any of these factors change, the Company may also change its original estimates, which could impact the level of the Company’s future allowance for doubtful accounts. If judgments regarding the collectability of receivables were incorrect, adjustments to the allowance may be required, which would reduce profitability.

Accounts receivable are recognized and carried at the original invoice amount less an allowance for any uncollectible amounts. An estimate for doubtful accounts receivable is made when collection of the full amount is no longer probable. Bad debts are written off as incurred. No allowance for doubtful accounts was made for the three and nine months ended September 30, 2021.

F-8

The following customers had an accounts receivable balance greater than 10% of total accounts receivable at September 30, 2021.

	Amount		%
Customer A	$	1,196,119		48	%
Customer B		1,289,211		52	%
	$	2,485,330		100	%

(d)

Advance to suppliers

Advance to suppliers relate to refundable deposits paid to suppliers under secured supplies agreements in exchange for timely and sufficient supplies of products.

(e)

Recently issued accounting pronouncements

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments.” This pronouncement, along with subsequent ASUs issued to clarify provisions of ASU 2016-13, changes the impairment model for most financial assets and will require the use of an “expected loss” model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. In developing the estimate for lifetime expected credit loss, entities must incorporate historical experience, current conditions, and reasonable and supportable forecasts. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019. On November 19, 2019, the FASB issued ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), finalized various effective date delays for private companies, not-for-profit organizations, and certain smaller reporting companies applying the credit losses (CECL), the revised effective date is January 2023.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this ASU on January 1, 2021 and determined it had no impact on its consolidated financial statements..

RISKS AND UNCERTAINTIES

(a)

Economic and Political Risks

The Company’s operations are conducted in the PRC. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environment in the PRC, and by the general state of the PRC economy.

The Company’s operations in the PRC are subject to special considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The Company’s results may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation.

(b)

Foreign Currency Translation

The Company’s reporting currency is the U.S. dollar. The functional currency of the parent company is the U.S. dollar and the functional currency of the Company’s operating subsidiaries is the Chinese Renminbi (“RMB”). For the subsidiaries whose functional currencies are the RMB, all assets and liabilities are translated at exchange rates at the balance sheet date and revenue and expenses are translated at the average yearly exchange rates and equity is translated at historical exchange rates. Any translation adjustments resulting are not included in determining net income but are included in foreign exchange adjustments to other comprehensive loss, a component of equity.

F-9

(c)

Concentration of credit risk

Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable, other receivables and amounts due from related parties. As of September 30, 2021 and December 31, 2020, substantially all of the Company’s cash and cash equivalents were deposited with financial institutions with high-credit ratings and quality. The Company did not have any customers constituting 10% or more of the net revenue in the nine months ended September 30, 2021 and 2020.

BUSINESS COMBINATION

On June 2, 2021, Shenzhen Wei Lian entered into an equity transfer agreement relating to the acquisition of 99% of the equity of Nainiang Wine in exchange for agreeing to cause the Company to issue 9,281,577 shares of its common stock to the Sellers. To determine the amount of shares that the Company issued to the Sellers, the Company converted the net asset value of Nainiang Wine as of June 3, 2021 to US Dollars, and then used a price per share for the Company’s common stock of US$1.10. The PRC Acquisition closed on June 3, 2021 and the results of operations of Nainiang Wine are included in the Company’s condensed consolidated financial statements beginning on June 3, 2021. The operational control of Nainiang Wine passed to FHAI and all assets of Nainiang Wine were acquired by FHAI effective June 3, 2021, the date that 99% of the outstanding equity of Nainiang Wine was transferred to Shenzhen Wei Lian. FHAI does not account for the remaining 1% non-controlling interest held by Ms. Zhu Hong, as Ms. Zhu Hong is the common controlling shareholder for both the acquirer and the acquiree.

Accordingly, the acquisition has been accounted for in accordance with ASC 805 guidelines, whereby FHAI recognized the assets and liabilities of Nainiang Wine transferred at their carrying amounts with a carry-over basis.

The following represents the purchase price allocation at the dates of the acquisition:

	June 3, 2021
Cash and cash equivalents	$	48,689
Other current assets		13,666,168
Property, plant and equipment		310,631
Current liabilities		(3,697,772	)
Total purchase price	$	10,327,716

REVENUE

Revenue	For the Three months ended September 30,
	2021		2020
Product sales	$	3,641,944	$	459,795
Franchise fees and income		743,150		-
Revenues from transactions with franchisees		10,660,302		-
	$	15,045,396	$	459,795

Revenue	For the Nine months ended September 30,
	2021		2020
Product sales	$	9,078,664	$	927,889
Franchise fees and income		889,296		-
Revenues from transactions with franchisees		18,947,081		-
	$	28,915,041	$	927,889

	As of September 30,		As of December 31,
Contract liabilities	2021		2020
Deferred revenue related to prepaid coffee and wine products	$	107,221	$	27,648
Deferred revenue related to upfront franchise fees		152,039		-
	$	259,260	$	27,648

F-10

Contract liabilities primarily consist of deferred revenue related to prepaid coffee and wine products and upfront franchise fees. Deferred revenue related to prepaid wine products represents advance from franchisees for future supply of products which is expected to recognize as revenue in the next 12 months. Deferred revenue related to upfront franchise fees represents the training service to be delivered over the term of franchise agreement that as of September 30, 2021, the Company expects to recognize as revenue of $152,039 within the next 12 months.

The Company has elected, as a practical expedient, not to disclose the value of remaining performance obligations associated with the franchise agreement in exchange for franchise right and related training services. The remaining duration of the performance obligation is the remaining contractual term of each franchise agreement. Revenue from training services provided to franchisees is recognized upon the conduct and delivery of training.

OTHER RECEIVABLES

As of September 30, 2021 and December 31, 2020, other receivables mainly consist of employees advance to be spent for company purposes and refundable rental deposits. The balances are unsecured, non-interest bearing and repayable on demand.

INVENTORY

	As of September 30,		As of December 31,
	2021		2020
Raw materials (1)	$	11,611,690	$	51,521
Finished goods		182,341		14,516
	$	11,794,031	$	66,037

(1)	Raw materials mainly consist of unprocessed coffee tea beans, unprocessed wine and packaging materials

PREPAYMENT

As of September 30, 2021 and December 31, 2020, prepayment mainly consists of prepaid administrative expenses that has been utilized subsequently.

10.

LEASEHOLD IMPROVEMENT AND EQUIPMENT, NET

	As of September 30,			As of December 31,
	2021			2020
Leasehold improvement	$	65,008		$	64,191
Equipment		20,975			16,653
Machinery		33,603			32,563
Computer equipment and software		41,373			20,355
Motor vehicle		442,759			7,245
	$	603,718		$	141,007
Less: accumulated depreciation		(190,355	)		(53,673	)
	$	413,363		$	87,333

Depreciation expense for the three and nine months ended September 30, 2021 and 2020 was $31,609, $55,833, $3,555 and $17,976 respectively.

11.

INTANGIBLE ASSETS

	As of September 30,			As of December 31,
	2021			2020
APP Platform	$	93,072		$	-
Less: accumulated amortization		(14,478	)		-
	$	78,594		$	-

Amortization expense for the three and nine months ended September 30, 2021 and 2020 was $12,739, $14,422, $nil and $1,628, respectively. The Company recorded an impairment loss on intangible assets of $76,365 to write off the old APP Platform during the year ended December 31, 2020.

F-11

12.

OTHER PAYABLES AND ACCRUALS

	As of June 30,		As of December 31,
	2021		2020
Accrued payroll and welfare payable	$	70,819	$	180,878
VAT and other taxes payable		786,850		92,608
Others ⁽¹⁾		40,849		63,118
	$	898,518	$	336,604

(1)	As of September 30, 2021 and December 31, 2020, others mainly consist of the outstanding refundable balance upon termination of the cooperative agreement with one customer and payables for rental expenses.

13.

INCOME TAXES

Fountain Healthy Aging, Inc. (“FHAI”) was incorporated in the State of Nevada. FHAI is an U.S. entity and is subject to the United States federal income tax. No provision for income taxes in the United States has been made as FHAI had no United States taxable income for the three and nine months ended September 30, 2021 and 2020.

Wei Lian Jin Meng Group Limited (“WLJM Cayman”) was incorporated in Cayman Islands. Under the current tax laws of Cayman Islands, WLJM Cayman is not subject to tax on their income or capital gains. In addition, upon dividends is being paid by WLJM Cayman to its shareholders, no Cayman Islands withholding tax will be imposed.

WLJM (Hong Kong) Limited (“WLJM HK”) was incorporated in Hong Kong and is subject to an income tax rate of 16.5% for taxable income generated from operations in Hong Kong.

Jin You Wei Meng (Shenzhen) Consulting Co., Ltd. (“JYWM WFOE”), Shenzhen Wei Lian Jin Meng Electronic Commerce Limited (“Shenzhen Wei Lian”), Dongguan Dishi Coffee Limited (“Dongguan Dishi”), Shenzhen Nainiang Coffee Art Museum Limited (“Nainiang Coffee”) and Nainiang Wine were incorporated in the PRC and they are subject to profits tax rate at 25% for income generated and operation in the country.

The full realization of the tax benefit associated with the losses carried forward depends predominantly upon the Company’s ability to generate taxable income during the carry forward period. The Company recognized deferred tax assets of $108,633 relating to tax losses carried forward as of September 30, 2021.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain.

The Company recorded deferred tax assets of $108,633 and $nil as of September 30, 2021 and December 31, 2020.

Income tax benefits

	For the three months ended September 30,
	2021		2020
Current tax expense	$	2,456,527	$	-
Deferred tax expense		92,172		-
	$	2,548,699	$	-

F-12

	For the nine months ended September 30,
	2021			2020
Current tax expense	$	4,799,020		$	-
Deferred tax benefits		(108,215	)		-
	$	4,690,805		$	-

A reconciliation of tax expense from 25% statutory tax rates for the three and nine months ended September 30, 2021 and 2020 is as follows:

	For the three months ended September 30,
	2021			2020
Profit (Loss) before tax	$	9,867,761		$	(351,435	)
Tax expense (benefit) calculated at statutory tax rate		25	%		25	%
Computed expected tax expense (benefit)		2,466,940			(87,859	)
Movement in valuation allowance		71,059			87,859
Others		10,700			-
	$	2,548,699		$	-

	For the nine months ended September 30,
	2021			2020
Profit (Loss) before tax	$	19,297,550		$	(590,347	)
Tax benefit calculated at statutory tax rate		25	%		25	%
Computed expected tax expense (benefit)		4,824,387			(147,587	)
Utilization of tax loss		(39,633	)		-
Movement in valuation allowance		(89,695	)		147,587
Others		(4,254	)		-
	$	4,690,805		$	-

14.

LEASES

The Company has leases for the office, factory and warehouse in the PRC, under operating leases expiring on various dates through September 2023, which is classified as operating leases. There are no residual value guarantees and no restrictions or covenants imposed by the leases. Lease liabilities are measured at present value of the sum of remaining rental payments as of September 30, 2021, with discounted rate of 4.75%. A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows. Rent expense for the three and nine months ended September 30, 2021 and 2020 were $81,135, $240,973, $66,870 and $196,005, respectively.

The Company’s future minimum payments under long-term non-cancelable operating leases are as follows:

	As of September 30, 2021
Within 1 year	$	162,800
After 1 year but within 5 years		22,844
Total lease payments	$	185,644
Less: imputed interest		(26,112	)
Total lease obligations		159,532
Less: current obligations		(139,483	)
Long-term lease obligations	$	20,049

F-13

Other information:

	For the nine months ended September 30,
	2021			2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases	$	240,973		$	196,005
Right-of-use assets obtained in exchange for operating lease liabilities		165,231			291,480
Remaining lease term for operating leases (years)		2			3
Weighted average discount rate for operating leases		4.75	%		4.75	%

15.

RELATED PARTIES TRANSACTIONS

The Company had the following balances with related parties:

(a)

Amount due from related parties

		As of September 30,		As of December 31,
	Relationship	2021		2020
Ye Aiyun	Shareholder of the Company	$	-	$	142,450
Shenzhen Weilian Jin Meng Culture Spreading Limited	Zhu Hong is the shareholder		52,762		-
		$	52,762	$	142,450

Amount due from a related parties represents cash advance to related parties. The balance is unsecured, non-interest bearing and repayable on demand.

(b)

Amount due to related parties

		As of September, 30		As of December 31,
	Relationship	2021		2020
Zhu Hong	Shareholder of the Company	$	79,491	$	1,059,853
Zhu Jian Yong	Shareholder of the Company		-		1,731
Shenzhen Weilian Jin Meng Culture Spreading Limited	Zhu Hong is the shareholder		-		24,800
Shenzhen Nainiang Wine Limited	Zhu Hong is the shareholder		-		10,768
Total		$	79,491	$	1,097,152

The balances represent cash advances to related parties, which were offset with the Company’s assets and expenses paid on behalf by the related parties. The balances with related parties are unsecured, non-interest bearing and repayable on demand.

16.

COMMITMENTS AND CONTINGENCIES

Commitment consists of a non-cancelable consultancy service agreement entered with a third-party for the provision of services related to the US listing with a contract sum of $1,200,000. The outstanding committed contract amount is $120,000. The terms of the agreement are for various milestones stages to be completed within two years through 2021. Future commitments within one year as of September 30, 2021 was $120,000. No future commitments more than one year as of September 30, 2021.

There are no other material commitments except for the above and the lease commitment as disclosed at Note 14.

17.

SUBSEQUENT EVENTS

No significant subsequent events have occurred that would require recognition or disclosure in the financial statements.

F-14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “pursue,” “expect,” “predict,” “project,” “goals,” “strategy,” “future,” “likely,” “forecast,” “potential,” “continue,” negatives thereof or similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding future acquisition or merger targets, business strategies, macro-economic and sector-specific trends, future cash flows, financing plans, plans and objectives of management and any other statements which are not statements of historical facts.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual future results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, inability to successfully conclude acquisitions of target companies or assets which are reasonably capable of generating positive cash flow in the near future, legal and regulatory changes in the jurisdictions in which we operate, volatility or decline in our stock price, potential fluctuation of our quarterly and annual financial and operational results, rapid adverse changes in markets, decline in demand for our goods and services, insufficient revenues to cover our operating costs and such other factors as discussed throughout this section.

Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated financial statements and the related notes included elsewhere in this report. Our consolidated financial statements have been prepared in accordance with U.S. GAAP. The following discussion and analysis contain forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those projected in the forward-looking statements. For additional information regarding these risks and uncertainties, please see this Part I, Item 2 (“Management’s Discussion and Analysis of Financial Condition and Results of Operations”) of this Quarterly Report on Form 10-Q.

Overview

The Company is a U.S. holding company incorporated in Nevada on February 25, 2004, and operating through the Company’s wholly owned subsidiary, Wei Lian Jin Meng Group Limited (“WLJM Cayman”), a company incorporated under the laws of the Cayman Islands on June 30, 2020. The Company’s entire business, including operations, employees, sales and marketing and research and development, are all conducted through its subsidiaries located within the People’s Republic of China (“PRC”).

The following is the organization structure of the Company along with ownership detail of all companies:

WLJM Cayman was incorporated in the Cayman Islands on June 30, 2020. It is 100% owned by Fountain Healthy Aging, Inc.

WLJM (Hong Kong) Limited (“WLJM HK”), was established in the Hong Kong Special Administrative Region (“HKSAR”) of the PRC on August 5, 2020. It is 100% owned by WLJM Cayman.

Jin You Wei Meng (Shenzhen) Consulting Company Limited (“JYWM WFOE”) was established as a wholly foreign-owned enterprise on November 24, 2020, under the laws of the PRC. It is 100% owned by WLJM HK.

Shenzhen Wei Lian Jin Meng Electronic Commerce Limited (“Shenzhen Wei Lian”) was incorporated on October 17, 2017, under the laws of the PRC. It is 100% owned by JYWM WFOE.

Dongguan Dishi Coffee Limited (“Dongguan Dishi”) was incorporated on October 25, 2018, under the laws of the PRC. It is 100% owned by Shenzhen Wei Lian.

Shenzhen Nainiang Coffee Art Museum Limited (“Nainiang Coffee”) was incorporated on June 20, 2019, under the laws of the PRC. It is 100% owned by Shenzhen Wei Lian.

Shenzhen Nainiang Wine Industrial Co., Ltd. (“Nainiang Wine”) was incorporated on January 14, 2020, under the laws of the PRC. It is 99% owned by Shenzhen Wei Lian.

The Company, through our subsidiaries, engaged in the business of wholesale distribution of “coffee tea” and wine products to retail partners and corporate customers, selling “coffee tea” and wine products to individual consumers and providing pre-opening assistance to retail partners to operate coffee and wine stores in the People’s Republic of China (“PRC” or “China”).

Critical Accounting Policies and Use of Estimates

We prepare our condensed consolidated financial statements in conformity with U.S. GAAP, which requires management to make certain estimates and to apply judgments. We base our estimates and judgments on historical experience, current trends and other factors that management believes to be important at the time the financial statements are prepared. On a regular basis, we review our accounting policies and how they are applied and disclosed in our condensed consolidated financial statements. Actual results could differ from those estimates made by management.

We believe that of our significant accounting policies, which are described in Note 3 to our condensed consolidated financial statements, the following accounting policies involve a greater degree of judgment and complexity. Accordingly, these are the policies we believe are the most critical to aid in fully understanding and evaluating our financial condition and results of operations.

Revenue Recognition

Our revenues primarily include product sales, franchise fees and income and revenues from transactions with franchisees.

Product sales

Product sales represents the sale of “coffee tea” and wine products. Such revenue is recognized net of value-added taxes, upon delivery at such time that title passes to the customers.

Franchise fees and income

Franchise fees and income primarily include upfront franchise fees, such as initial fees, pre-opening assistance to operate wine stores, subsequent training provided to franchisees and renewal fees. We have determined that the services provided in exchange for upfront franchise fees are highly interrelated with the franchise rights. The franchise rights are accounted for as rights to access our symbolic intellectual property in accordance with ASC 606, and we recognize upfront franchise fees received from a franchisee as revenue when performance obligations are satisfied in accordance with the franchise agreement or the renewal agreement. The franchise agreement term is typically 3 years.

Revenues from transactions with franchisees

Revenues from transactions with franchisees consist primarily of sales of wine products. We sell and deliver wine products to the franchisees. The performance obligations arising from such transactions are considered distinct from the franchise agreement as they are not highly dependent on the franchise agreement and the customer can benefit from the procurement service on its own. Revenue is recognized upon transfer of control over ordered items, generally upon delivery to the franchisees.

In determining the amount and timing of revenue from contracts with customers, we exercise significant judgment with respect to collectability of the amount; however, the timing of recognition does not require significant judgment, as it is based on either the franchise term or the date of product shipment, none of which require estimation.

We do not incur a significant amount of contract acquisition costs in conducting its franchising activities. We believe its franchising arrangements do not contain a significant financing component.

Our revenue recognition policy is compliant with ASC 606, Revenue from Contracts with Customers, and revenue is recognized when a customer obtains control of promised goods and is recognized in an amount that reflects the consideration that we expect to receive in exchange for those goods. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that we expect to receive in exchange for those goods. We apply the following five-step model in order to determine this amount:

	(i)	identification of the goods and services in the contract;

	(ii)	determination of whether the goods and services are performance obligations, including whether they are distinct in the context of the contract;

	(iii)	measurement of the transaction price, including the constraint on variable consideration;

	(iv)	allocation of the transaction price to the performance obligations; and

	(v)	recognition of revenue when (or as) the Company satisfies each performance obligation.

We only apply the five-step model to contracts when it is probable that we will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, we review the contract to determine which performance obligations we must deliver and which of these performance obligations are distinct. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery or service being rendered.

For all reporting periods, we have not disclosed the value of unsatisfied performance obligations for all product revenue contracts with an original expected length of one year or less, which is an optional exemption that is permitted under the adopted rules.

Revenue	For the Three months ended September 30,
	2021		2020
Product sales	$	3,641,944	$	459,795
Franchise fees and income		743,150		-
Revenues from transactions with franchisees		10,660,302		-
	$	15,045,396	$	459,795

Revenue	For the Nine months ended September 30,
	2021		2020
Product sales	$	9,078,664	$	927,889
Franchise fees and income		889,296		-
Revenues from transactions with franchisees		18,947,081		-
	$	28,915,041	$	927,889

	As of September 30,		As of December 31,
Contract liabilities	2021		2020
Deferred revenue related to prepaid coffee and wine products	$	107,221	$	27,648
Deferred revenue related to upfront franchise fees		152,039		-
	$	259,260	$	27,648

Contract liabilities primarily consist of deferred revenue related to prepaid wine products and upfront franchise fees. Deferred revenue related to prepaid wine products represents advance from franchisees for future supply of products which is expected to be recognized as revenue in the next 12 months. Deferred revenue related to upfront franchise fees represents the training service to be delivered over the term of franchise agreement that as of June 30, 2021, we expect to recognize revenue of $152,039 within the next 12 months.

We have elected, as a practical expedient, not to disclose the value of remaining performance obligations associated with the franchise agreement in exchange for franchise right and related training services. The remaining duration of the performance obligation is the remaining contractual term of each franchise agreement. Revenue from training services provided to franchisees is recognized upon the conduct and delivery of training.

Concentrations of Credit Risk

Financial instruments that potentially expose us to significant concentration of credit risk consist primarily of cash and cash equivalents, accounts receivable, other receivables, prepayment and advance to suppliers. As of September 30, 2021 and December 31, 2020, substantially all of our cash and cash equivalents were deposited with financial institutions with high-credit ratings and quality. The following customers had an accounts receivable balance greater than 10% of total accounts receivable at September 30, 2021.

	Amount		%
Customer A	$	1,196,119		48	%
Customer B		1,289,211		52	%
	$	2,485,330		100	%

We did not have customers constituting 10% or more of the net revenues in the three and nine months ended September 30, 2021 and 2020.

Recently Issued and Adopted Accounting Pronouncements

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. We are currently evaluating the impacts of the provisions of ASU 2019-12 on its financial condition, results of operations, and cash flows.

Results of Operations

Comparison of Three Months Ended September 30, 2021 and 2020

The following discussion should be read in conjunction with the condensed consolidated financial statements of Fountain Healthy Aging, Inc. attached hereto for the three months ended September 30, 2021 and 2020.

Revenue

We generated $15,045,396 in revenue for the three months ended September 30, 2021 compared to $459,795 for the three months ended September 30, 2020. There was an increase in total revenues of $14,585,601 or 3172% compared with the three months ended September 30, 2021.

Our business is gradually recovering from the COVID-19 pandemic which has been less severe than in 2020. The measures taken by the Chinese government to contain the virus have been effective, business has returned to normal and the market has substantially regained confidence. The recovery of the economy has positively affected our results, and we earned a significant portion of revenue from our new wine products that were launched in January 2021. In addition, we acquired Nainiang Wine on June 3, 2021, which contributed $10,893,592 to our consolidated revenue for the three months ended September 30, 2021.

Cost of Revenue

Cost of revenue was $4,430,256 for the three months ended September 30, 2021 compared to $24,943 for the three months ended September 30, 2020. The increase of cost of revenue by $4,405,313 or 17662% was relatively in line with the increase in revenue. The cost of revenue consists of the cost of raw materials and cost of manufactured goods sold to customers, including labor cost, rental expense, research, and development costs, etc.. The acquisition of Nainiang Wine contributed $3,828,364 to our consolidated cost of revenue for the three months ended September 30, 2021.

Gross profit

Gross profit for the three months ended September 30, 2021 was $10,615,140 compared with $373,552 for the three months ended September 30, 2020. The decrease in gross profit margin of 71% for the three months ended September 30, 2021 compared to 81% for the three months ended September 30, 2020 was due to a lower margin for the new wine products and the lower gross profit margin from the acquisition of Nainiang Wine. The gross profit margin of Nainiang Wine for the three months ended September 30, 2021 was 65%.

Operating Expenses

Selling and marketing expenses

Our selling expenses for the three months ended September 30, 2021 and 2020 was $219,006 and $24,943, respectively. Selling expenses consist primarily of salary and welfare for sales staff, advertising expense and exhibition expense. The increase of selling and marketing expenses by $194,063 or 778% was relatively in line with the increase in revenue. In addition, the acquisition of Nainiang Wine contributed $140,708 to our consolidated selling and marketing expenses.

General and administrative expense

By far the most significant component of our operating expenses for both the three months ended September 30, 2021 and 2020 was general and administrative expenses of $525,927 and $700,095, respectively. The following table sets forth the main components of our general and administrative expenses for the three months ended September 30, 2021 and 2020.

	For the three months ended September 30,
	2021					2020
	Amount (US$)		% of Total			Amount (US$)		% of Total
General and administrative expense:
Consultancy fee	$	239,582		45	%	$	250,454		36	%
Salary and welfare		135,404		26	%		132,871		19	%
Rental expenses		60,756		11	%		66,870		10	%
Research and development costs		-		-	%		1,689		0	%
Office expenses		25,256		5	%		29,532		4	%
Travel and accommodations		4,339		1	%		8,720		1	%
Entertainment		13,326		3	%		7,104		1	%
Impairment losses on long-lived assets		-		-	%		76,199		11	%
Others		47,204		9	%		126,656		18	%
Total general and administrative expenses	$	525,927		100	%	$	700,095		100	%

The $174,168, or 25%, decrease in general and administrative expenses, from $700,095 for the three months ended September 30, 2020 to $525,927 for the three months ended September 30, 2021, was mainly due to the decrease in consultant fees that was significantly incurred during the year of 2020 for the services provided by the Company’s consultants in connection with the reverse acquisition of WLJM Cayman. The acquisition of Nainiang Wine contributed $111,644 to our consolidated general and administrative expenses.

Net Profit

We reported a net profit of $7,319,062 for the three months ended September 30, 2021 compared to a net loss of $(351,435) for the three months ended September 30, 2020, an increase of $7,670,497 or 2183%. The increase was primarily attributable to the fact that our revenue has increased significantly, whereas the increase in administrative expenses is lower than the increase of revenue, because the decrease in consultant fees and some expenses are fixed costs in nature. In addition, the acquisition of Nainiang Wine contributed $5,097,498 to our consolidated net profit for the three months ended September 30, 2021.

Comparison of Nine Months Ended September 30, 2021 and 2020

The following discussion should be read in conjunction with the condensed consolidated financial statements of Fountain Healthy Aging, Inc. attached hereto for the nine months ended September 30, 2021 and 2020.

Revenue

We generated $28,915,041 in revenue for the nine months ended September 30, 2021 compared to $927,889 for the nine months ended September 30, 2020. There was an increase in total revenues of $27,987,152 or 3016% compared with the nine months ended September 30, 2020.

Our business is gradually recovering from the COVID-19 pandemic, which has been less severe than in 2020. The measures taken by the Chinese government to contain the virus have been effective, business has returned to normal and the market has substantially regained confidence. The recovery of the economy has positively affected our results, and we earned a significant portion of revenue from our new wine products that was launched in January 2021. In addition, we acquired Nainiang Wine on June 3, 2021, which contributed $15,537,182 to our consolidated revenue for the nine months ended September 30, 2021.

Cost of Revenue

Cost of revenue was $8,141,174 for the nine months ended September 30, 2021 compared to $155,541 for the nine months ended September 30, 2020. The increase of cost of revenue by $7,985,633 or 5134% was relatively in line with the increase in revenue. The cost of revenue consists of the cost of raw materials and cost of manufactured goods sold to customers, including labor cost, rental expense, research, and development costs, etc.. The acquisition of Nainiang Wine contributed $5,522,914 to our consolidated cost of revenue for the nine months ended September 30, 2021.

Gross profit

Gross profit for the nine months ended September 30, 2021 was $20,773,867 compared with $772,348 for the nine months ended September 30, 2020. The decrease in gross profit margin of 72% for the nine months ended September 30, 2021 compared to 83% for the nine months ended September 30, 2020 was due to a lower margin for the new wine products and the lower gross profit margin from the acquisition of Nainiang Wine. The gross profit margin of Nainiang Wine for the nine months ended September 30, 2021 was 64%.

Operating Expenses

Selling and marketing expenses

Our selling expenses for the nine months ended September 30, 2021 and 2020 was $392,350 and $84,087, respectively. Selling expenses consist primarily of salary and welfare for sales staff, advertising expense and exhibition expense. The increase of selling and marketing expenses by $308,263 or 367% was relatively in line with the increase in revenue. In addition, the acquisition of Nainiang Wine contributed $168,956 to our consolidated selling and marketing expenses for the nine months ended September 30, 2021.

General and administrative expense

By far the most significant component of our operating expenses for both the nine months ended September 30, 2021 and 2020 was general and administrative expenses of $1,087,491 and $1,279,879, respectively. The following table sets forth the main components of our general and administrative expenses for the nine months ended September 30, 2021 and 2020.

	For the nine months ended September 30,
	2021					2020
	Amount (US$)		% of Total			Amount (US$)		% of Total
General and administrative expense:
Consultancy fee	$	456,433		42	%	$	447,375		35	%
Salary and welfare		223,541		21	%		269,339		21	%
Rental expenses		220,594		20	%		196,005		15	%
Research and development costs		44,263		4	%		49,986		4	%
Office expenses		38,467		4	%		36,633		3	%
Travel and accommodations		17,016		1	%		17,560		1	%
Entertainment		20,297		2	%		10,833		1	%
Impairment losses on long-lived assets		-		-			76,199		6	%
Others		66,880		6	%		175,949		14	%
Total general and administrative expenses	$	1,087,491		100	%	$	1,279,879		100	%

Decrease in general and administrative expenses by $192,388 or 15% from $1,279,879 for the nine months ended September 30, 2020 to $1,087,491 for the nine months ended September 30, 2021. The general and administrative expenses remained stable due to their fixed costs in nature. The acquisition of Nainiang Wine contributed $125,500 to our consolidated general and administrative expenses for the nine months ended September 30, 2021.

Net Profit

We incurred a net profit of $14,606,745 for the nine months ended September 30, 2021 compared to a net loss of $(590,347) for the nine months ended September 30, 2020, an increase of $19,887,897 or 3369%. The increase was primarily attributable to the fact that our revenue has increased significantly, whereas the increase in administrative expenses is lower than the increase of revenue, because some expenses are fixed costs in nature. In addition, the acquisition of Nainiang Wine contributed $7,278,228 to our consolidated net profit for the nine months ended September 30, 2021.

Liquidity and Capital Resources

	September 30,			December 31,
	2021			2020
Working capital:
Total current assets	$	27,300,723		$	505,082
Total current liabilities		(4,224,475	)		(1,947,717	)
Working capital surplus (deficiency)	$	23,076,248		$	(1,442,635	)

As of September 30, 2021, we had cash and cash equivalents of $1,220,174. To date, we have financed our operations primarily through working capital generated from our profitable business. The following table provides detailed information about our net cash flows for the nine months ended September 30, 2021 and 2020:

	2021			2020
Cash flows:
Net cash provided by operating activities	$	1,272,046			74,823
Net cash used in investing activities		(117,859	)		-
Effect of exchange rate changes on cash and cash equivalents		4,470			2,836
Net increase in cash and cash equivalents		1,158,657			77,659
Cash and cash equivalents at the beginning of year		61,517			23,046
Cash and cash equivalents at the end of the nine-month period	$	1,220,174			100,705

Operating Activities

Net cash provided by operating activities was $1,272,046 for the nine months ended September 30, 2021. The difference between our net profit of $14,606,745 and net cash provided by operating activities was mainly attributable to the depreciation of fixed assets and amortization of intangible assets of $70,255, and the decrease in other operating assets and liabilities of $837,810 which was generally due to the increase in income tax payables which offset with decrease in advance to suppliers, inventory, accounts payables, other payables and accruals and amount due from/to related parties.

Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2021 was $118,637, as compared to nil for the nine months ended September 30, 2020. The increase in cash provided by investing activities was mainly attributable to cash acquired from the acquisition of Nainiang Wine, which was offset by the decrease in cash from the acquisition of leasehold improvements and equipment and intangible assets during the nine months ended September 30, 2021. We will evaluate and assess the COVID-19 pandemic impact to our business to determine the plan for increasing our capital expenditures in the future periods.

Contractual Obligations and Commercial Commitments

We had the following contractual obligations and commercial commitments as of September 30, 2021:

	Total		Less than 1 year		1-5 years		More than 5 years
Operating lease	$	185,644	$	162,800	$	22,844	$	-
Consultancy service		120,000		120,000		-		-
		305,644		282,800		22,844		-

For the nine months ended June 30, 2021 and 2020, we entered into various operating lease agreement during the fiscal year 2018 and 2019, and expiring on varying dates through September 2023. The average monthly lease expense is approximately $26,184. The outstanding lease commitment as of September 30, 2021 was $185,644.

During 2019, we entered into a non-cancelable consultancy service agreement with a third-party for the provision of services related to the US listing with the contract amount of $1,200,000. The outstanding commitment as of September 30, 2021 was $120,000.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a “smaller reporting company,” we are not required to provide the information required by this Item.

Item 4. Controls and Procedures

Management’s Report on Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our president (our principal executive officer and principal financial officer) to allow for timely decisions regarding required disclosure.

As of the end of the quarter covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our president (our principal executive officer, principal financial officer and principle accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures. Our management’s relative inexperience with the reporting requirements of public companies under the Exchange Act, as recently evidenced by the long delay we experienced in reporting the acquisition of Nainiang Wine by Shenzhen Wei Lian, which closed on June 3, 2021 and which was reported in the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 16, 2021, is a source of substantial concern and risk, and considering all components of our assessment, our president (our principal executive officer and principal financial officer) concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Controls

There have been no changes in our internal controls over financial reporting that occurred during the quarter ended September 30, 2021, that have materially or are reasonably likely to materially affect, our internal controls over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

Item 1A. Risk Factors

As a “smaller reporting company,” we are not required to provide the information required by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On August 16, 2021, the Company issued 9,281,577 shares of the Company’s common stock to the owners (the “Sellers”) of Nainiang Wine, in exchange for the transfer by the Sellers of 99% of the equity ownership interests in Nainiang Wine (the “Acquisition”). The Company reported the Acquisition in its Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 16, 2021.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit Number		Description
31.1*		Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of the Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Filed herewith.
**	Deemed furnished and not filed.

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Fountain healthy aging, inc.
	(Registrant)

Dated: November 15, 2021	/s/ Zhu Hong
	Zhu Hong
	President, Chief Executive Officer and Director
	(Principal Executive Officer)

EX-31.1 2 f10q0921ex31-1_fountain.htm CERTIFICATION

Exhibit 31.1

I, Zhu Hong, certify that:

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 of Fountain Healthy Aging, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 15, 2021

/s/ Zhu Hong
Zhu Hong
President, Chief Executive Officer and Director (Principal Executive Officer)

EX-31.2 3 f10q0921ex31-2_fountain.htm CERTIFICATION

Exhibit 31.2

I, Zhu Hong, certify that:

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 of Fountain Healthy Aging, Inc.;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 15, 2021

/s/ Zhu Hong
Zhu Hong
Chief Financial Officer, Treasurer and Director (Principal Financial Officer and Principal Accounting Officer)

EX-32.1 4 f10q0921ex32-1_fountain.htm CERTIFICATION

Exhibit 32.1

SECTION 1350 CERTIFICATIONS

This Certificate is being delivered pursuant to the requirements of Section 1350 of Chapter 63 (Mail Fraud) of Title 18 (Crimes and Criminal Procedures) of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

The undersigned, who is the Chief Executive Officer of Fountain Healthy Aging, Inc. (the “Company”), hereby certifies to his knowledge as follows:

The Quarterly Report on Form 10-Q of the Company, which accompanies this Certificate, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and all information contained in this Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 15, 2021	/s/ Zhu Hong
	Zhu Hong
	President, Chief Executive Officer and Director (Principal Executive Officer) Fountain Healthy Aging, Inc.

EX-32.2 5 f10q0921ex32-2_fountain.htm CERTIFICATION

Exhibit 32.2

SECTION 1350 CERTIFICATIONS

The undersigned, who is the Chief Financial Officer of Fountain Healthy Aging, Inc. (the “Company”), hereby certifies to his knowledge as follows:

Dated: November 15, 2021	/s/ Zhu Hong
	Zhu Hong
	Chief Financial Officer, Treasurer and Director (Principal Financial Officer and Principal Accounting Officer) Fountain Healthy Aging, Inc.

EX-101.SCH 6 fhai-20210930.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Changes in Equity (Deficit) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Description of Business link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Risks and Uncertainties link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Business Combination link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Revenue link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Other Receivables link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Inventory link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Prepayment link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Leasehold Improvement and Equipment, Net link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Other Payables and Accruals link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Related Parties Transactions link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Business Combination (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Revenue (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Inventory (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Leasehold Improvement and Equipment, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Other Payables and Accruals (Tables) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Related Parties Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Description of Business (Details) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of accounts receivable link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Risks and Uncertainties (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Business Combination (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Business Combination (Details) - Schedule of represents the purchase price link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Revenue (Details) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Revenue (Details) - Schedule of revenue link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Revenue (Details) - Schedule of contract liabilities link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Inventory (Details) - Schedule of inventory link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Leasehold Improvement and Equipment, Net (Details) link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Leasehold Improvement and Equipment, Net (Details) - Schedule of leasehold improvement and equipment, net link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Intangible Assets (Details) - Schedule of intangible assets link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Other Payables and Accruals (Details) link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Other Payables and Accruals (Details) - Schedule of other payables and accruals link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - Income Taxes (Details) - Schedule of income tax benefits link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - Income Taxes (Details) - Schedule of statutory tax rates link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - Leases (Details) link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - Leases (Details) - Schedule of future minimum payments under long-term non-cancelable operating leases link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - Leases (Details) - Schedule of other information link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - Related Parties Transactions (Details) - Schedule of amount due from related parties link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - Related Parties Transactions (Details) - Schedule of amount due to related parties link:presentationLink link:definitionLink link:calculationLink 058 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 fhai-20210930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 fhai-20210930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 fhai-20210930_lab.xml XBRL LABEL FILE Statement of Financial Position [Abstract] Total current assets Total non-current assets Total assets Total current liabilities Total non-current liabilities Total liabilities Class of Stock [Axis] Total equity (deficit) Balance Balance Total liabilities and equity Income Statement [Abstract] Gross profit Total operating expenses Operating profit (loss) Profit (Loss) before income taxes Profit (Loss) before tax Net profit (loss) for the period Total comprehensive income (loss) for the period Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Statement of Cash Flows [Abstract] Net cash provided by operating activities Net cash used in investing activities Net increase in cash and cash equivalents Cash and cash equivalents at the beginning of year Cash and cash equivalents at the end of the year Cash and cash equivalents Accounting Policies [Abstract] Schedule of accounts receivable [Abstract] Customer [Axis] Risks and Uncertainties [Abstract] Business Combinations [Abstract] Schedule of represents the purchase price [Abstract] Total purchase price Revenue from Contract with Customer [Abstract] Schedule of revenue [Abstract] Schedule of contract liabilities [Abstract] Contract liabilities Receivables [Abstract] Inventory Disclosure [Abstract] Schedule of inventory [Abstract] Inventory, total Inventory Other Income and Expenses [Abstract] Property, Plant and Equipment [Abstract] Schedule of leasehold improvement and equipment, net [Abstract] Long-Lived Tangible Asset [Axis] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of intangible assets [Abstract] Intangible assets, net Intangible assets Payables and Accruals [Abstract] Schedule of other payables and accruals [Abstract] Other payables and accruals Income Tax Disclosure [Abstract] Schedule of income tax benefits [Abstract] Schedule of statutory tax rates [Abstract] ASU 2016-02 Transition [Abstract] Schedule of future minimum payments under long-term non-cancelable operating leases [Abstract] Total lease payments Total lease obligations Long-term lease obligations Schedule of other information [Abstract] Related Party Transactions [Abstract] Schedule of amount due from related parties [Abstract] Related Party Transaction [Axis] Schedule of amount due to related parties [Abstract] Commitments and Contingencies Disclosure [Abstract] Subsequent Events [Abstract] Document Type Document Quarterly Report Document Period End Date Document Fiscal Year Focus Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Entity Central Index Key ASSETS Current assets: Accounts receivable Other receivables Prepayment Advance to suppliers Amount due from related parties Non-current assets: Leasehold improvements and equipment, net Operating lease right-of-use assets Deferred tax assets LIABILITIES AND EQUITY Current liabilities: Accounts payable Income tax payables Other payables and accruals Deferred revenue Amount due to related parties Current operating lease liabilities Non-current liabilities: Non-current operating lease liabilities COMMITMENTS AND CONTINGENCIES EQUITY (DEFICIT) Share capital (750,000,000 shares of Common Stock, par value $0.00001 per share, authorized, of which 609,316,077 and 600,034,500 shares are issued and outstanding as of September 30, 2021 and December 31, 2020, respectively; and 100,000,000 shares of Series A Preferred Stock, par value $0.00001 per share, of which all 100,000,000 shares are issued and outstanding) Common Stock, shares authorized Common Stock, par value (in Dollars per share) Common Stock, shares issued Common Stock, shares outstanding Series A Preferred Stock, shares authorized Series A Preferred Stock, par value (in Dollars per share) Series A preferred Stock, shares issued Series A preferred Stock, shares outstanding Series A Preferred Stock Common Stock Additional paid in capital Foreign currency translation reserves Retained earnings (Accumulated deficit) Revenue Other income, net Foreign currency translation differences Earnings per share: - Basic (in Dollars per share) - Diluted (in Dollars per share) Weighted average number of shares used in computation: - Basic (in Shares) - Diluted (in Shares) Profit (loss) for the period Net profit (loss) Other comprehensive income (Loss) Business combination under common control Cash flows from operating activities: Adjustments for: Depreciation and amortization Impairment of intangible assets Changes in: Advance to suppliers Accounts payable, other payables and accruals Income tax payables Deferred revenue Amount due from/to related parties Cash flows from investing activities: Effect of exchange rate changes on cash and cash equivalents Supplemental disclosure of non-cash investing and financing activities: Income tax paid Right-of-use assets obtained in exchange for operating lease obligations Cost of revenue Selling and marketing expenses General and administrative expense Income taxes Accounts receivable Other receivables and prepayment Inventory Deferred tax assets Additions to leasehold improvements and equipment Additions to intangible assets Cash acquired from business combination Series A preferred Stock Series A preferred Stock Common Stock Additional paid in Capital Foreign Currency Translation Reserve (Accumulated Deficit) Retain Earnings Unrestricted (Accumulated Deficit) Retain Earnings Statutory Reserve DESCRIPTION OF BUSINESS BASIS OF PRESENTATION SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Schedule of accounts receivable Accounts receivable amount Accounts receivable percentage RISKS AND UNCERTAINTIES BUSINESS COMBINATION Schedule of represents the purchase price Cash and cash equivalents Other current assets Property, plant and equipment REVENUE Schedule of revenue Product sales EX-101.PRE 10 fhai-20210930_pre.xml XBRL PRESENTATION FILE XML 11 f10q0921_fountainhealthy_htm.xml IDEA: XBRL DOCUMENT 0001309251 2021-01-01 2021-09-30 0001309251 2021-11-12 0001309251 2021-09-30 0001309251 2020-12-31 0001309251 us-gaap:SeriesAPreferredStockMember 2021-09-30 0001309251 us-gaap:SeriesAPreferredStockMember 2020-12-31 0001309251 2021-07-01 2021-09-30 0001309251 2020-07-01 2020-09-30 0001309251 2020-01-01 2020-09-30 0001309251 us-gaap:PreferredStockMember 2019-12-31 0001309251 us-gaap:CommonStockMember 2019-12-31 0001309251 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001309251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001309251 us-gaap:RetainedEarningsMember 2019-12-31 0001309251 us-gaap:RetainedEarningsAppropriatedMember 2019-12-31 0001309251 2019-12-31 0001309251 us-gaap:PreferredStockMember 2020-01-01 2020-09-30 0001309251 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001309251 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001309251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001309251 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001309251 us-gaap:RetainedEarningsAppropriatedMember 2020-01-01 2020-09-30 0001309251 us-gaap:PreferredStockMember 2020-09-30 0001309251 us-gaap:CommonStockMember 2020-09-30 0001309251 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001309251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001309251 us-gaap:RetainedEarningsMember 2020-09-30 0001309251 us-gaap:RetainedEarningsAppropriatedMember 2020-09-30 0001309251 2020-09-30 0001309251 us-gaap:PreferredStockMember 2020-12-31 0001309251 us-gaap:CommonStockMember 2020-12-31 0001309251 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001309251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001309251 us-gaap:RetainedEarningsMember 2020-12-31 0001309251 us-gaap:RetainedEarningsAppropriatedMember 2020-12-31 0001309251 us-gaap:PreferredStockMember 2021-01-01 2021-09-30 0001309251 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001309251 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001309251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001309251 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001309251 us-gaap:RetainedEarningsAppropriatedMember 2021-01-01 2021-09-30 0001309251 us-gaap:PreferredStockMember 2021-09-30 0001309251 us-gaap:CommonStockMember 2021-09-30 0001309251 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001309251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001309251 us-gaap:RetainedEarningsMember 2021-09-30 0001309251 us-gaap:RetainedEarningsAppropriatedMember 2021-09-30 0001309251 fhai:ShenzhenWeiLianMember 2021-06-02 0001309251 fhai:FHAIMember 2021-08-16 0001309251 fhai:CustomerAMember 2021-01-01 2021-09-30 0001309251 fhai:CustomerBMember 2021-01-01 2021-09-30 0001309251 us-gaap:SalesRevenueNetMember 2021-01-01 2021-09-30 0001309251 us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001309251 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-06-02 0001309251 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-05-22 2021-06-02 0001309251 fhai:ShenzhensWeiLianMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-06-02 0001309251 fhai:MsZhuHongAsMsZhuHongMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-06-02 0001309251 2021-06-03 0001309251 us-gaap:LeaseholdImprovementsMember 2021-09-30 0001309251 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001309251 us-gaap:EquipmentMember 2021-09-30 0001309251 us-gaap:EquipmentMember 2020-12-31 0001309251 us-gaap:MachineryAndEquipmentMember 2021-09-30 0001309251 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001309251 sic:Z3570 2021-09-30 0001309251 sic:Z3570 2020-12-31 0001309251 us-gaap:VehiclesMember 2021-09-30 0001309251 us-gaap:VehiclesMember 2020-12-31 0001309251 2020-01-01 2020-12-31 0001309251 country:HK 2021-01-01 2021-09-30 0001309251 country:CN 2021-01-01 2021-09-30 0001309251 fhai:YeAiyunMember 2021-01-01 2021-09-30 0001309251 fhai:YeAiyunMember 2021-09-30 0001309251 fhai:YeAiyunMember 2020-12-31 0001309251 fhai:ShenzhenWeilianJinMengCultureSpreadingLimitedMember 2021-01-01 2021-09-30 0001309251 fhai:ShenzhenWeilianJinMengCultureSpreadingLimitedMember 2021-09-30 0001309251 fhai:ShenzhenWeilianJinMengCultureSpreadingLimitedMember 2020-12-31 0001309251 fhai:ZhuHongMember 2021-01-01 2021-09-30 0001309251 fhai:ZhuHongMember 2021-09-30 0001309251 fhai:ZhuHongMember 2020-12-31 0001309251 fhai:ZhuJianYongMember 2021-01-01 2021-09-30 0001309251 fhai:ZhuJianYongMember 2021-09-30 0001309251 fhai:ZhuJianYongMember 2020-12-31 0001309251 fhai:ShenzhenNainiangWineLimitedMember 2021-01-01 2021-09-30 0001309251 fhai:ShenzhenNainiangWineLimitedMember 2021-09-30 0001309251 fhai:ShenzhenNainiangWineLimitedMember 2020-12-31 shares iso4217:USD iso4217:USD shares pure 10-Q true 2021-09-30 2021 false 333-123774 Fountain Healthy Aging, Inc. NV 86-1098668 Room 601, Bldg. E, No. 1 Huabao Fubao China Street Shenzhen 518000 +86 185 6676 1769 Yes Yes Non-accelerated Filer true true false false 609316077

1220174

61517

2485330

179466

101432

11794031

66037

12558

133646

11556402

52762

142450

27300723

505082

413363

87333

78594

159532

383203

108633

760122

470536

28060845

975618

456339

134842

2391384

31774

898518

336604

259260

27648

79491

1097152

139483

319697

4224475

1947717

20049

63506

20049

63506

4244524

2011223

750000000

0.00001

609316077

600034500

100000000

0.00001

100000000

1000

6093

6000

10215427

-15146

-134240

-54091

13728041

-973368

23816321

-1035605

28060845

975618

15045396

459795

28915041

927889

4430256

86243

8141174

155541

10615140

373552

20773867

772348

219006

24943

392350

84087

525927

700095

1087491

1279879

744933

725038

1479841

1363966

9870207

-351486

19294026

-591618

-2446

3524

1271

9867761

-351435

19297550

-590347

2548699

4690805

7319062

-351435

14606745

-590347

58282

-31511

-80149

-25516

7377344

-382946

14526596

-615863

0.012

0.024

0.001

0.012

0.024

0.001

604574402

600034500

601564430

600034500

604574402

600034500

601564430

600034500

1000

6000

-15146

4547

-352392

6894

-349097

-590347

-25516

1000

6000

-15146

-20969

-942739

6894

-964960

1000

6000

-15146

-54091

-980262

6894

-1035605

10230573

94664

10325330

14606745

-80149

1000

6093

10215427

-134240

13626483

101558

23816321

14606745

-590347

70255

17976

76199

1205866

133260

-75544

158153

7092718

-9225

-3953044

79544

108215

-1029640

171314

939691

-71027

-202827

-959679

805152

1272046

74823

104739

61809

-48689

-117859

4470

2836

1158657

77659

61517

23046

1220174

100705

3761784

165231 291480

0.99

9281577

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">3.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(a)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Use of estimates</td></tr> </table> The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ materially from those estimates. There is no change on the accounting policies from the year ended December 31, 2020. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(b)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Revenue Recognition</td></tr> </table> The Company’s revenues primarily include Company sales, franchise fees and income and revenues from transactions with franchisees. Product sales Product sales represents the sale of “coffee tea” and wine products. Such revenue is recognized net of value-added taxes, upon delivery at such time that title passes to the customers. Franchise fees and income Franchise fees and income primarily include upfront franchise fees, such as initial fees, pre-opening assistance to operate wine stores, subsequent training provided to franchisees and renewal fees. The Company has determined that the services provided in exchange for upfront franchise fees are highly interrelated with the franchise rights. The franchise rights are accounted for as rights to access the Company’s symbolic intellectual property in accordance with ASC 606, and the Company recognizes upfront franchise fees received from a franchisee as revenue when performance obligations are satisfied in accordance with the franchise agreement or the renewal agreement. The franchise agreement term is typically 3 years. Revenues from transactions with franchisees Revenues from transactions with franchisees consist primarily of sales of wine products. The Company sells and delivers wine products to the franchisees. The performance obligations arising from such transactions are considered distinct from the franchise agreement as they are not highly dependent on the franchise agreement and the customer can benefit from the procurement service on its own. Revenue is recognized upon transfer of control over ordered items, generally upon delivery to the franchisees. In determining the amount and timing of revenue from contracts with customers, the Company exercises significant judgment with respect to collectability of the amount; however, the timing of recognition does not require significant judgment, as it is based on either the franchise term or the date of product shipment, none of which require estimation. The Company does not incur a significant amount of contract acquisition costs in conducting its franchising activities. The Company believes its franchising arrangements do not contain a significant financing component. The Company’s revenue recognition policy is compliant with ASC 606, Revenue from Contracts with Customers, and revenue is recognized when a customer obtains control of promised goods and is recognized in an amount that reflects the consideration that the Company expects to receive in exchange for those goods. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(i)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">identification of the goods and services in the contract;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(ii)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">determination of whether the goods and services are performance obligations, including whether they are distinct in the context of the contract;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(iii)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">measurement of the transaction price, including the constraint on variable consideration;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(iv)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">allocation of the transaction price to the performance obligations; and</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(v)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">recognition of revenue when (or as) the Company satisfies each performance obligation.</td></tr> </table> The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery or service being rendered. For all reporting periods, the Company has not disclosed the value of unsatisfied performance obligations for all product revenue contracts with an original expected length of one year or less, which is an optional exemption that is permitted under the adopted rules. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(c)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Accounts Receivable</td></tr> </table> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable. The Company assesses the probability of collection from each customer at the outset of the arrangement based on a number of factors, including the customer’s payment history and its current creditworthiness. If in management’s judgment collection is not probable, the Company does not record revenue until the uncertainty is removed. Management performs ongoing credit evaluations, and the Company maintains an allowance for potential credit losses based upon its loss history and its aging analysis. The allowance for doubtful accounts is the Company’s best estimate of the amount of credit losses in existing accounts receivable. Management reviews the allowance for doubtful accounts each reporting period based on a detailed analysis of trade receivables. In the analysis, management primarily considers the age of the customer’s receivable, and also considers the creditworthiness of the customer, the economic conditions of the customer’s industry, general economic conditions and trends, and the business relationship and history with its customers, among other factors. If any of these factors change, the Company may also change its original estimates, which could impact the level of the Company’s future allowance for doubtful accounts. If judgments regarding the collectability of receivables were incorrect, adjustments to the allowance may be required, which would reduce profitability. Accounts receivable are recognized and carried at the original invoice amount less an allowance for any uncollectible amounts. An estimate for doubtful accounts receivable is made when collection of the full amount is no longer probable. Bad debts are written off as incurred. No allowance for doubtful accounts was made for the three and nine months ended September 30, 2021. The following customers had an accounts receivable balance greater than 10% of total accounts receivable at September 30, 2021. <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,196,119</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">48</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Customer B</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,289,211</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,485,330</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 4pt; text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: left">(d)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Advance to suppliers</td></tr> </table> Advance to suppliers relate to refundable deposits paid to suppliers under secured supplies agreements in exchange for timely and sufficient supplies of products. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(e)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recently issued accounting pronouncements</td></tr> </table> In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments.” This pronouncement, along with subsequent ASUs issued to clarify provisions of ASU 2016-13, changes the impairment model for most financial assets and will require the use of an “expected loss” model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. In developing the estimate for lifetime expected credit loss, entities must incorporate historical experience, current conditions, and reasonable and supportable forecasts. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019. On November 19, 2019, the FASB issued ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), finalized various effective date delays for private companies, not-for-profit organizations, and certain smaller reporting companies applying the credit losses (CECL), the revised effective date is January 2023. In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this ASU on January 1, 2021 and determined it had no impact on its consolidated financial statements..

P3Y

0.10

1196119

0.48

1289211

0.52

2485330

1 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: left">(d)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Advance to suppliers</td></tr> </table> Advance to suppliers relate to refundable deposits paid to suppliers under secured supplies agreements in exchange for timely and sufficient supplies of products.

0.10 0.10

0.99

9281577

1.1

0.99

0.01

48689

13666168

310631

3697772

10327716

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify">Revenue</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Product sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,641,944</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">459,795</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Franchise fees and income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">743,150</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Revenues from transactions with franchisees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,660,302</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">15,045,396</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">459,795</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify">Revenue</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Nine months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Product sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,078,664</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">927,889</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Franchise fees and income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">889,296</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Revenues from transactions with franchisees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,947,081</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28,915,041</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">927,889</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 3641944 459795 743150

10660302

15045396

459795

9078664 927889 889296

18947081

28915041

927889

259260

27648

152039

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center">As of September 30,</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">As of December 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2021</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2020</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%; text-align: justify">Raw materials (1)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">11,611,690</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">51,521</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Finished goods</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">182,341</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">14,516</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"> </td> <td> </td> <td style="border-bottom: black 4.5pt double">$</td> <td style="border-bottom: black 4.5pt double; text-align: right">11,794,031</td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double">$</td> <td style="border-bottom: black 4.5pt double; text-align: right">66,037</td> <td> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">(1)</td> <td style="text-align: justify">Raw materials mainly consist of unprocessed coffee tea beans, unprocessed wine and packaging materials</td></tr> </table>

11611690

51521

182341

14516

11794031

66037

65008

64191

20975

16653

33603

32563

41373

20355

442759

7245

603718

141007

190355

53673

413363

87333

31609

55833

3555

17976

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center">As of September 30,</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">As of December 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2021</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2020</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%; text-align: justify">APP Platform</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">93,072</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">-</div></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Less: accumulated amortization</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(14,478</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"> </td> <td> </td> <td style="border-bottom: black 4.5pt double">$</td> <td style="border-bottom: black 4.5pt double; text-align: right">78,594</td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double">$</td> <td style="border-bottom: black 4.5pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td> <td> </td></tr> </table>

93072

14478

78594

12739

14422

1628

76365

70819

180878

786850

92608

40849

63118

898518

336604

1 1

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0px"/><td style="width: 24px; text-align: left">13.</td><td style="text-align: justify">INCOME TAXES</td> </tr></table> Fountain Healthy Aging, Inc. (“FHAI”) was incorporated in the State of Nevada. FHAI is an U.S. entity and is subject to the United States federal income tax. No provision for income taxes in the United States has been made as FHAI had no United States taxable income for the three and nine months ended September 30, 2021 and 2020. Wei Lian Jin Meng Group Limited (“WLJM Cayman”) was incorporated in Cayman Islands. Under the current tax laws of Cayman Islands, WLJM Cayman is not subject to tax on their income or capital gains. In addition, upon dividends is being paid by WLJM Cayman to its shareholders, no Cayman Islands withholding tax will be imposed. WLJM (Hong Kong) Limited (“WLJM HK”) was incorporated in Hong Kong and is subject to an income tax rate of 16.5% for taxable income generated from operations in Hong Kong. Jin You Wei Meng (Shenzhen) Consulting Co., Ltd. (“JYWM WFOE”), Shenzhen Wei Lian Jin Meng Electronic Commerce Limited (“Shenzhen Wei Lian”), Dongguan Dishi Coffee Limited (“Dongguan Dishi”), Shenzhen Nainiang Coffee Art Museum Limited (“Nainiang Coffee”) and Nainiang Wine were incorporated in the PRC and they are subject to profits tax rate at 25% for income generated and operation in the country. The full realization of the tax benefit associated with the losses carried forward depends predominantly upon the Company’s ability to generate taxable income during the carry forward period. The Company recognized deferred tax assets of $108,633 relating to tax losses carried forward as of September 30, 2021. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The Company recorded deferred tax assets of $108,633 and $nil as of September 30, 2021 and December 31, 2020. Income tax benefits <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the three months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Current tax expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,456,527</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Deferred tax expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">92,172</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,548,699</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">Current tax expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,799,020</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Deferred tax benefits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(108,215</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,690,805</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> A reconciliation of tax expense from 25% statutory tax rates for the three and nine months ended September 30, 2021 and 2020 is as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the three months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Profit (Loss) before tax</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">9,867,761</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(351,435</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Tax expense (benefit) calculated at statutory tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Computed expected tax expense (benefit)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,466,940</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(87,859</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Movement in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71,059</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87,859</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,700</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,548,699</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Profit (Loss) before tax</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">19,297,550</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(590,347</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Tax benefit calculated at statutory tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Computed expected tax expense (benefit)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,824,387</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(147,587</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Utilization of tax loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(39,633</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Movement in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(89,695</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">147,587</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,254</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,690,805</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

0.165

0.25

108633

2456527

92172

2548699

4799020

-108215

4690805

0.25

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the three months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Profit (Loss) before tax</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">9,867,761</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(351,435</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Tax expense (benefit) calculated at statutory tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Computed expected tax expense (benefit)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,466,940</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(87,859</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Movement in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71,059</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87,859</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,700</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,548,699</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Profit (Loss) before tax</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">19,297,550</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(590,347</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Tax benefit calculated at statutory tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Computed expected tax expense (benefit)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,824,387</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(147,587</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Utilization of tax loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(39,633</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Movement in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(89,695</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">147,587</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,254</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,690,805</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

9867761

-351435

0.25 0.25

2466940

-87859

71059 87859

10700

2548699

19297550

-590347

0.25 0.25

4824387

-147587

39633

-89695 147587

-4254

4690805

0.0475

81135

240973

66870

196005

162800

22844

185644

26112

159532

139483

20049

240973

196005

165231

291480

P2Y

P3Y

0.0475

Shareholder of the Company

142450

Zhu Hong is the shareholder

52762

142450

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"> </td><td> </td> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">As of September, 30</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 45%; text-align: left">Zhu Hong</td><td style="width: 1%"> </td> <td style="width: 30%; text-align: left">Shareholder of the Company</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">79,491</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,059,853</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Zhu Jian Yong</td><td> </td> <td style="text-align: left">Shareholder of the Company</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,731</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Shenzhen Weilian Jin Meng Culture Spreading Limited</td><td> </td> <td style="text-align: left">Zhu Hong is the shareholder</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,800</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Shenzhen Nainiang Wine Limited</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Zhu Hong is the shareholder</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,768</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">79,491</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,097,152</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

Shareholder of the Company

79491

1059853

Shareholder of the Company

1731

Zhu Hong is the shareholder

24800

Zhu Hong is the shareholder

10768

79491

1097152

the US listing with a contract sum of $1,200,000. The outstanding committed contract amount is $120,000. The terms of the agreement are for various milestones stages to be completed within two years through 2021. Future commitments within one year as of September 30, 2021 was $120,000. No future commitments more than one year as of September 30, 2021.

false --12-31 Q3 0001309251 Raw materials mainly consist of unprocessed coffee tea beans, unprocessed wine and packaging materials As of September 30, 2021 and December 31, 2020, others mainly consist of the outstanding refundable balance upon termination of the cooperative agreement with one customer and payables for rental expenses.

XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2021	Nov. 12, 2021
Document Information Line Items
Entity Registrant Name	Fountain Healthy Aging, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		609,316,077
Amendment Flag	false
Entity Central Index Key	0001309251
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-123774
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	86-1098668
Entity Address, Address Line One	Room 601, Bldg. E,
Entity Address, Address Line Two	No. 1
Entity Address, Address Line Three	Huabao Fubao China Street
Entity Address, City or Town	Shenzhen
Entity Address, Country	BB
Entity Address, Postal Zip Code	518000
City Area Code	+86
Local Phone Number	185 6676 1769
Entity Interactive Data Current	Yes

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 1,220,174	$ 61,517
Accounts receivable	2,485,330
Other receivables	179,466	101,432
Inventory	11,794,031	66,037
Prepayment	12,558	133,646
Advance to suppliers	11,556,402
Amount due from related parties	52,762	142,450
Total current assets	27,300,723	505,082
Non-current assets:
Leasehold improvements and equipment, net	413,363	87,333
Intangible assets	78,594
Operating lease right-of-use assets	159,532	383,203
Deferred tax assets	108,633
Total non-current assets	760,122	470,536
Total assets	28,060,845	975,618
Current liabilities:
Accounts payable	456,339	134,842
Income tax payables	2,391,384	31,774
Other payables and accruals	898,518	336,604
Deferred revenue	259,260	27,648
Amount due to related parties	79,491	1,097,152
Current operating lease liabilities	139,483	319,697
Total current liabilities	4,224,475	1,947,717
Non-current liabilities:
Non-current operating lease liabilities	20,049	63,506
Total non-current liabilities	20,049	63,506
Total liabilities	4,244,524	2,011,223
COMMITMENTS AND CONTINGENCIES
EQUITY (DEFICIT)
Share capital (750,000,000 shares of Common Stock, par value $0.00001 per share, authorized, of which 609,316,077 and 600,034,500 shares are issued and outstanding as of September 30, 2021 and December 31, 2020, respectively; and 100,000,000 shares of Series A Preferred Stock, par value $0.00001 per share, of which all 100,000,000 shares are issued and outstanding)
Series A Preferred Stock	1,000	1,000
Common Stock	6,093	6,000
Additional paid in capital	10,215,427	(15,146)
Foreign currency translation reserves	(134,240)	(54,091)
Retained earnings (Accumulated deficit)	13,728,041	(973,368)
Total equity (deficit)	23,816,321	(1,035,605)
Total liabilities and equity	$ 28,060,845	$ 975,618

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Common Stock, shares authorized	750,000,000	750,000,000
Common Stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Common Stock, shares issued	609,316,077	600,034,500
Common Stock, shares outstanding	609,316,077	600,034,500
Series A preferred Stock
Series A Preferred Stock, shares authorized	100,000,000	100,000,000
Series A Preferred Stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Series A preferred Stock, shares issued	100,000,000	100,000,000
Series A preferred Stock, shares outstanding	100,000,000	100,000,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 15,045,396	$ 459,795	$ 28,915,041	$ 927,889
Cost of revenue	(4,430,256)	(86,243)	(8,141,174)	(155,541)
Gross profit	10,615,140	373,552	20,773,867	772,348
Selling and marketing expenses	(219,006)	(24,943)	(392,350)	(84,087)
General and administrative expense	(525,927)	(700,095)	(1,087,491)	(1,279,879)
Total operating expenses	(744,933)	(725,038)	(1,479,841)	(1,363,966)
Operating profit (loss)	9,870,207	(351,486)	19,294,026	(591,618)
Other income, net	(2,446)	51	3,524	1,271
Profit (Loss) before income taxes	9,867,761	(351,435)	19,297,550	(590,347)
Income taxes	(2,548,699)		(4,690,805)
Net profit (loss) for the period	7,319,062	(351,435)	14,606,745	(590,347)
Foreign currency translation differences	58,282	(31,511)	(80,149)	(25,516)
Total comprehensive income (loss) for the period	$ 7,377,344	$ (382,946)	$ 14,526,596	$ (615,863)
Earnings per share:
- Basic (in Dollars per share)	$ 0.012	$ 0	$ 0.024	$ 0.001
- Diluted (in Dollars per share)	$ 0.012	$ 0	$ 0.024	$ 0.001
Weighted average number of shares used in computation:
- Basic (in Shares)	604,574,402	600,034,500	601,564,430	600,034,500
- Diluted (in Shares)	604,574,402	600,034,500	601,564,430	600,034,500

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Changes in Equity (Deficit) (Unaudited) - USD ($)	Series A preferred Stock	Common Stock	Additional paid in Capital	Foreign Currency Translation Reserve	(Accumulated Deficit) Retain Earnings Unrestricted	(Accumulated Deficit) Retain Earnings Statutory Reserve	Total
Balance at Dec. 31, 2019	$ 1,000	$ 6,000	$ (15,146)	$ 4,547	$ (352,392)	$ 6,894	$ (349,097)
Profit (loss) for the period					(590,347)		(590,347)
Other comprehensive income (Loss)				(25,516)			(25,516)
Balance at Sep. 30, 2020	1,000	6,000	(15,146)	(20,969)	(942,739)	6,894	(964,960)
Balance at Dec. 31, 2020	1,000	6,000	(15,146)	(54,091)	(980,262)	6,894	(1,035,605)
Business combination under common control		93	10,230,573			94,664	10,325,330
Profit (loss) for the period					14,606,745		14,606,745
Other comprehensive income (Loss)				(80,149)			(80,149)
Balance at Sep. 30, 2021	$ 1,000	$ 6,093	$ 10,215,427	$ (134,240)	$ 13,626,483	$ 101,558	$ 23,816,321

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net profit (loss)	$ 14,606,745	$ (590,347)
Adjustments for:
Depreciation and amortization	70,255	17,976
Impairment of intangible assets		76,199
Changes in:
Accounts receivable	(1,205,866)	(133,260)
Other receivables and prepayment	75,544	(158,153)
Inventory	(7,092,718)	9,225
Advance to suppliers	(3,953,044)	79,544
Deferred tax assets	(108,215)
Accounts payable, other payables and accruals	(1,029,640)	171,314
Income tax payables	939,691
Deferred revenue	(71,027)	(202,827)
Amount due from/to related parties	(959,679)	805,152
Net cash provided by operating activities	1,272,046	74,823
Cash flows from investing activities:
Additions to leasehold improvements and equipment	(104,739)
Additions to intangible assets	(61,809)
Cash acquired from business combination	48,689
Net cash used in investing activities	(117,859)
Effect of exchange rate changes on cash and cash equivalents	4,470	2,836
Net increase in cash and cash equivalents	1,158,657	77,659
Cash and cash equivalents at the beginning of year	61,517	23,046
Cash and cash equivalents at the end of the year	1,220,174	100,705
Supplemental disclosure of non-cash investing and financing activities:
Income tax paid	3,761,784
Right-of-use assets obtained in exchange for operating lease obligations	$ 165,231	$ 291,480

XML 18 R7.htm IDEA: XBRL DOCUMENT

Description of Business

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS

XML 19 R8.htm IDEA: XBRL DOCUMENT

Basis of Presentation

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION

XML 20 R9.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a)

Use of estimates

There is no change on the accounting policies from the year ended December 31, 2020.

(b)

Revenue Recognition

The Company’s revenues primarily include Company sales, franchise fees and income and revenues from transactions with franchisees.

Product sales

Product sales represents the sale of “coffee tea” and wine products. Such revenue is recognized net of value-added taxes, upon delivery at such time that title passes to the customers.

Franchise fees and income

Revenues from transactions with franchisees

(i)

identification of the goods and services in the contract;

(ii)

determination of whether the goods and services are performance obligations, including whether they are distinct in the context of the contract;

(iii)

measurement of the transaction price, including the constraint on variable consideration;

(iv)

allocation of the transaction price to the performance obligations; and

(v)

recognition of revenue when (or as) the Company satisfies each performance obligation.

(c)

Accounts Receivable

The following customers had an accounts receivable balance greater than 10% of total accounts receivable at September 30, 2021.

	Amount		%
Customer A	$	1,196,119		48	%
Customer B		1,289,211		52	%
	$	2,485,330		100	%

(d)

Advance to suppliers

Advance to suppliers relate to refundable deposits paid to suppliers under secured supplies agreements in exchange for timely and sufficient supplies of products.

(e)

Recently issued accounting pronouncements

XML 21 R10.htm IDEA: XBRL DOCUMENT

Risks and Uncertainties

9 Months Ended

Sep. 30, 2021

Risks and Uncertainties [Abstract]

RISKS AND UNCERTAINTIES

RISKS AND UNCERTAINTIES

(a)

Economic and Political Risks

(b)

Foreign Currency Translation

(c)

Concentration of credit risk

XML 22 R11.htm IDEA: XBRL DOCUMENT

Business Combination

9 Months Ended

Sep. 30, 2021

Business Combinations [Abstract]

BUSINESS COMBINATION

BUSINESS COMBINATION

The following represents the purchase price allocation at the dates of the acquisition:

	June 3, 2021
Cash and cash equivalents	$	48,689
Other current assets		13,666,168
Property, plant and equipment		310,631
Current liabilities		(3,697,772	)
Total purchase price	$	10,327,716

XML 23 R12.htm IDEA: XBRL DOCUMENT

Revenue

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

REVENUE

REVENUE

Revenue	For the Three months ended September 30,
	2021		2020
Product sales	$	3,641,944	$	459,795
Franchise fees and income		743,150		-
Revenues from transactions with franchisees		10,660,302		-
	$	15,045,396	$	459,795

Revenue	For the Nine months ended September 30,
	2021		2020
Product sales	$	9,078,664	$	927,889
Franchise fees and income		889,296		-
Revenues from transactions with franchisees		18,947,081		-
	$	28,915,041	$	927,889

	As of September 30,		As of December 31,
Contract liabilities	2021		2020
Deferred revenue related to prepaid coffee and wine products	$	107,221	$	27,648
Deferred revenue related to upfront franchise fees		152,039		-
	$	259,260	$	27,648

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

+ Details

XML 24 R13.htm IDEA: XBRL DOCUMENT

Other Receivables

9 Months Ended

Sep. 30, 2021

Receivables [Abstract]

OTHER RECEIVABLES

OTHER RECEIVABLES

XML 25 R14.htm IDEA: XBRL DOCUMENT

Inventory

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

INVENTORY

INVENTORY

	As of September 30,		As of December 31,
	2021		2020
Raw materials (1)	$	11,611,690	$	51,521
Finished goods		182,341		14,516
	$	11,794,031	$	66,037

(1)	Raw materials mainly consist of unprocessed coffee tea beans, unprocessed wine and packaging materials

XML 26 R15.htm IDEA: XBRL DOCUMENT

Prepayment

9 Months Ended

Sep. 30, 2021

Other Income and Expenses [Abstract]

PREPAYMENT

PREPAYMENT

As of September 30, 2021 and December 31, 2020, prepayment mainly consists of prepaid administrative expenses that has been utilized subsequently.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Leasehold Improvement and Equipment, Net

9 Months Ended

Sep. 30, 2021

Property, Plant and Equipment [Abstract]

LEASEHOLD IMPROVEMENT AND EQUIPMENT, NET

10.

LEASEHOLD IMPROVEMENT AND EQUIPMENT, NET

	As of September 30,			As of December 31,
	2021			2020
Leasehold improvement	$	65,008		$	64,191
Equipment		20,975			16,653
Machinery		33,603			32,563
Computer equipment and software		41,373			20,355
Motor vehicle		442,759			7,245
	$	603,718		$	141,007
Less: accumulated depreciation		(190,355	)		(53,673	)
	$	413,363		$	87,333

Depreciation expense for the three and nine months ended September 30, 2021 and 2020 was $31,609, $55,833, $3,555 and $17,976 respectively.

XML 28 R17.htm IDEA: XBRL DOCUMENT

Intangible Assets

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS

11.

INTANGIBLE ASSETS

	As of September 30,			As of December 31,
	2021			2020
APP Platform	$	93,072		$	-
Less: accumulated amortization		(14,478	)		-
	$	78,594		$	-

XML 29 R18.htm IDEA: XBRL DOCUMENT

Other Payables and Accruals

9 Months Ended

Sep. 30, 2021

Payables and Accruals [Abstract]

OTHER PAYABLES AND ACCRUALS

12.

OTHER PAYABLES AND ACCRUALS

	As of June 30,		As of December 31,
	2021		2020
Accrued payroll and welfare payable	$	70,819	$	180,878
VAT and other taxes payable		786,850		92,608
Others ⁽¹⁾		40,849		63,118
	$	898,518	$	336,604

(1)	As of September 30, 2021 and December 31, 2020, others mainly consist of the outstanding refundable balance upon termination of the cooperative agreement with one customer and payables for rental expenses.

XML 30 R19.htm IDEA: XBRL DOCUMENT

Income Taxes

9 Months Ended

Sep. 30, 2021

Income Tax Disclosure [Abstract]

INCOME TAXES

13.

INCOME TAXES

WLJM (Hong Kong) Limited (“WLJM HK”) was incorporated in Hong Kong and is subject to an income tax rate of 16.5% for taxable income generated from operations in Hong Kong.

The Company recorded deferred tax assets of $108,633 and $nil as of September 30, 2021 and December 31, 2020.

Income tax benefits

	For the three months ended September 30,
	2021		2020
Current tax expense	$	2,456,527	$	-
Deferred tax expense		92,172		-
	$	2,548,699	$	-

	For the nine months ended September 30,
	2021			2020
Current tax expense	$	4,799,020		$	-
Deferred tax benefits		(108,215	)		-
	$	4,690,805		$	-

A reconciliation of tax expense from 25% statutory tax rates for the three and nine months ended September 30, 2021 and 2020 is as follows:

	For the three months ended September 30,
	2021			2020
Profit (Loss) before tax	$	9,867,761		$	(351,435	)
Tax expense (benefit) calculated at statutory tax rate		25	%		25	%
Computed expected tax expense (benefit)		2,466,940			(87,859	)
Movement in valuation allowance		71,059			87,859
Others		10,700			-
	$	2,548,699		$	-

	For the nine months ended September 30,
	2021			2020
Profit (Loss) before tax	$	19,297,550		$	(590,347	)
Tax benefit calculated at statutory tax rate		25	%		25	%
Computed expected tax expense (benefit)		4,824,387			(147,587	)
Utilization of tax loss		(39,633	)		-
Movement in valuation allowance		(89,695	)		147,587
Others		(4,254	)		-
	$	4,690,805		$	-

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 31 R20.htm IDEA: XBRL DOCUMENT

Leases

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

LEASES

14.

LEASES

The Company’s future minimum payments under long-term non-cancelable operating leases are as follows:

	As of September 30, 2021
Within 1 year	$	162,800
After 1 year but within 5 years		22,844
Total lease payments	$	185,644
Less: imputed interest		(26,112	)
Total lease obligations		159,532
Less: current obligations		(139,483	)
Long-term lease obligations	$	20,049

Other information:

	For the nine months ended September 30,
	2021			2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases	$	240,973		$	196,005
Right-of-use assets obtained in exchange for operating lease liabilities		165,231			291,480
Remaining lease term for operating leases (years)		2			3
Weighted average discount rate for operating leases		4.75	%		4.75	%

XML 32 R21.htm IDEA: XBRL DOCUMENT

Related Parties Transactions

9 Months Ended

Sep. 30, 2021

RELATED PARTIES TRANSACTIONS

15.

RELATED PARTIES TRANSACTIONS

The Company had the following balances with related parties:

(a)

Amount due from related parties

		As of September 30,		As of December 31,
	Relationship	2021		2020
Ye Aiyun	Shareholder of the Company	$	-	$	142,450
Shenzhen Weilian Jin Meng Culture Spreading Limited	Zhu Hong is the shareholder		52,762		-
		$	52,762	$	142,450

Amount due from a related parties represents cash advance to related parties. The balance is unsecured, non-interest bearing and repayable on demand.

(b)

Amount due to related parties

		As of September, 30		As of December 31,
	Relationship	2021		2020
Zhu Hong	Shareholder of the Company	$	79,491	$	1,059,853
Zhu Jian Yong	Shareholder of the Company		-		1,731
Shenzhen Weilian Jin Meng Culture Spreading Limited	Zhu Hong is the shareholder		-		24,800
Shenzhen Nainiang Wine Limited	Zhu Hong is the shareholder		-		10,768
Total		$	79,491	$	1,097,152

XML 33 R22.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

16.

COMMITMENTS AND CONTINGENCIES

There are no other material commitments except for the above and the lease commitment as disclosed at Note 14.

XML 34 R23.htm IDEA: XBRL DOCUMENT

Subsequent Events

9 Months Ended

Sep. 30, 2021

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

17.

SUBSEQUENT EVENTS

No significant subsequent events have occurred that would require recognition or disclosure in the financial statements.

XML 35 R24.htm IDEA: XBRL DOCUMENT

Accounting Policies, by Policy (Policies)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Use of estimates

(a)

Use of estimates

There is no change on the accounting policies from the year ended December 31, 2020.

Revenue Recognition

(b)

Revenue Recognition

The Company’s revenues primarily include Company sales, franchise fees and income and revenues from transactions with franchisees.

Product sales

Product sales represents the sale of “coffee tea” and wine products. Such revenue is recognized net of value-added taxes, upon delivery at such time that title passes to the customers.

Franchise fees and income

Revenues from transactions with franchisees

(i)

identification of the goods and services in the contract;

(ii)

determination of whether the goods and services are performance obligations, including whether they are distinct in the context of the contract;

(iii)

measurement of the transaction price, including the constraint on variable consideration;

(iv)

allocation of the transaction price to the performance obligations; and

(v)

recognition of revenue when (or as) the Company satisfies each performance obligation.

Accounts Receivable

(c)

Accounts Receivable

The following customers had an accounts receivable balance greater than 10% of total accounts receivable at September 30, 2021.

	Amount		%
Customer A	$	1,196,119		48	%
Customer B		1,289,211		52	%
	$	2,485,330		100	%

Advance to suppliers

(d)

Advance to suppliers

Advance to suppliers relate to refundable deposits paid to suppliers under secured supplies agreements in exchange for timely and sufficient supplies of products.

Recently issued accounting pronouncements

(e)

Recently issued accounting pronouncements

XML 36 R25.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Schedule of accounts receivable

	Amount		%
Customer A	$	1,196,119		48	%
Customer B		1,289,211		52	%
	$	2,485,330		100	%

XML 37 R26.htm IDEA: XBRL DOCUMENT

Business Combination (Tables)

9 Months Ended

Sep. 30, 2021

Business Combinations [Abstract]

Schedule of represents the purchase price

	June 3, 2021
Cash and cash equivalents	$	48,689
Other current assets		13,666,168
Property, plant and equipment		310,631
Current liabilities		(3,697,772	)
Total purchase price	$	10,327,716

XML 38 R27.htm IDEA: XBRL DOCUMENT

Revenue (Tables)

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

Schedule of revenue

Revenue	For the Three months ended September 30,
	2021		2020
Product sales	$	3,641,944	$	459,795
Franchise fees and income		743,150		-
Revenues from transactions with franchisees		10,660,302		-
	$	15,045,396	$	459,795

Revenue	For the Nine months ended September 30,
	2021		2020
Product sales	$	9,078,664	$	927,889
Franchise fees and income		889,296		-
Revenues from transactions with franchisees		18,947,081		-
	$	28,915,041	$	927,889

Schedule of contract liabilities

	As of September 30,		As of December 31,
Contract liabilities	2021		2020
Deferred revenue related to prepaid coffee and wine products	$	107,221	$	27,648
Deferred revenue related to upfront franchise fees		152,039		-
	$	259,260	$	27,648

XML 39 R28.htm IDEA: XBRL DOCUMENT

Inventory (Tables)

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

Schedule of inventory

	As of September 30,		As of December 31,
	2021		2020
Raw materials (1)	$	11,611,690	$	51,521
Finished goods		182,341		14,516
	$	11,794,031	$	66,037

(1)	Raw materials mainly consist of unprocessed coffee tea beans, unprocessed wine and packaging materials

XML 40 R29.htm IDEA: XBRL DOCUMENT

Leasehold Improvement and Equipment, Net (Tables)

9 Months Ended

Sep. 30, 2021

Property, Plant and Equipment [Abstract]

Schedule of leasehold improvement and equipment, net

	As of September 30,			As of December 31,
	2021			2020
Leasehold improvement	$	65,008		$	64,191
Equipment		20,975			16,653
Machinery		33,603			32,563
Computer equipment and software		41,373			20,355
Motor vehicle		442,759			7,245
	$	603,718		$	141,007
Less: accumulated depreciation		(190,355	)		(53,673	)
	$	413,363		$	87,333

XML 41 R30.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of intangible assets

	As of September 30,			As of December 31,
	2021			2020
APP Platform	$	93,072		$	-
Less: accumulated amortization		(14,478	)		-
	$	78,594		$	-

XML 42 R31.htm IDEA: XBRL DOCUMENT

Other Payables and Accruals (Tables)

9 Months Ended

Sep. 30, 2021

Payables and Accruals [Abstract]

Schedule of other payables and accruals

	As of June 30,		As of December 31,
	2021		2020
Accrued payroll and welfare payable	$	70,819	$	180,878
VAT and other taxes payable		786,850		92,608
Others ⁽¹⁾		40,849		63,118
	$	898,518	$	336,604

(1)	As of September 30, 2021 and December 31, 2020, others mainly consist of the outstanding refundable balance upon termination of the cooperative agreement with one customer and payables for rental expenses.

XML 43 R32.htm IDEA: XBRL DOCUMENT

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2021

Income Tax Disclosure [Abstract]

Schedule of income tax benefits

	For the three months ended September 30,
	2021		2020
Current tax expense	$	2,456,527	$	-
Deferred tax expense		92,172		-
	$	2,548,699	$	-

	For the nine months ended September 30,
	2021			2020
Current tax expense	$	4,799,020		$	-
Deferred tax benefits		(108,215	)		-
	$	4,690,805		$	-

Schedule of statutory tax rates

	For the three months ended September 30,
	2021			2020
Profit (Loss) before tax	$	9,867,761		$	(351,435	)
Tax expense (benefit) calculated at statutory tax rate		25	%		25	%
Computed expected tax expense (benefit)		2,466,940			(87,859	)
Movement in valuation allowance		71,059			87,859
Others		10,700			-
	$	2,548,699		$	-

	For the nine months ended September 30,
	2021			2020
Profit (Loss) before tax	$	19,297,550		$	(590,347	)
Tax benefit calculated at statutory tax rate		25	%		25	%
Computed expected tax expense (benefit)		4,824,387			(147,587	)
Utilization of tax loss		(39,633	)		-
Movement in valuation allowance		(89,695	)		147,587
Others		(4,254	)		-
	$	4,690,805		$	-

XML 44 R33.htm IDEA: XBRL DOCUMENT

Leases (Tables)

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

Schedule of future minimum payments under long-term non-cancelable operating leases

	As of September 30, 2021
Within 1 year	$	162,800
After 1 year but within 5 years		22,844
Total lease payments	$	185,644
Less: imputed interest		(26,112	)
Total lease obligations		159,532
Less: current obligations		(139,483	)
Long-term lease obligations	$	20,049

Schedule of other information

	For the nine months ended September 30,
	2021			2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases	$	240,973		$	196,005
Right-of-use assets obtained in exchange for operating lease liabilities		165,231			291,480
Remaining lease term for operating leases (years)		2			3
Weighted average discount rate for operating leases		4.75	%		4.75	%

XML 45 R34.htm IDEA: XBRL DOCUMENT

Related Parties Transactions (Tables)

9 Months Ended

Sep. 30, 2021

Schedule of amount due from related parties

		As of September 30,		As of December 31,
	Relationship	2021		2020
Ye Aiyun	Shareholder of the Company	$	-	$	142,450
Shenzhen Weilian Jin Meng Culture Spreading Limited	Zhu Hong is the shareholder		52,762		-
		$	52,762	$	142,450

Schedule of amount due to related parties

		As of September, 30		As of December 31,
	Relationship	2021		2020
Zhu Hong	Shareholder of the Company	$	79,491	$	1,059,853
Zhu Jian Yong	Shareholder of the Company		-		1,731
Shenzhen Weilian Jin Meng Culture Spreading Limited	Zhu Hong is the shareholder		-		24,800
Shenzhen Nainiang Wine Limited	Zhu Hong is the shareholder		-		10,768
Total		$	79,491	$	1,097,152

XML 46 R35.htm IDEA: XBRL DOCUMENT

Description of Business (Details) - shares	Aug. 16, 2021	Jun. 02, 2021
Shenzhen Wei Lian [Member]
Description of Business (Details) [Line Items]
Percentage of ownership		99.00%
FHAI [Member]
Description of Business (Details) [Line Items]
Share issued	9,281,577

XML 47 R36.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details)	9 Months Ended
Summary of Significant Accounting Policies (Details)	Sep. 30, 2021
Accounting Policies [Abstract]
Agreement term	3 years
Percentage of accounts receivable	10.00%

XML 48 R37.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details) - Schedule of accounts receivable	9 Months Ended
	Sep. 30, 2021 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable amount	$ 2,485,330
Accounts receivable percentage	100.00%
Customer A [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable amount	$ 1,196,119
Accounts receivable percentage	48.00%
Customer B [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable amount	$ 1,289,211
Accounts receivable percentage	52.00%

XML 49 R38.htm IDEA: XBRL DOCUMENT

Risks and Uncertainties (Details)	9 Months Ended
Risks and Uncertainties (Details)	Sep. 30, 2021	Sep. 30, 2020
Net revenue [Member]
Risks and Uncertainties (Details) [Line Items]
Concentration risk percentage	10.00%	10.00%

XML 50 R39.htm IDEA: XBRL DOCUMENT

Business Combination (Details) - Business Acquisition [Member]	Jun. 02, 2021 $ / shares shares
Business Combination (Details) [Line Items]
Percentage of acquisition	99.00%
Shares issued (in Shares) \| shares	9,281,577
Common stock price per share (in Dollars per share) \| $ / shares	$ 1.1
Shenzhen Wei Lian [Member]
Business Combination (Details) [Line Items]
Percentage of acquisition	99.00%
Ms. Zhu Hong, as Ms. Zhu Hong [Member]
Business Combination (Details) [Line Items]
Percentage of acquisition	1.00%

XML 51 R40.htm IDEA: XBRL DOCUMENT

Business Combination (Details) - Schedule of represents the purchase price	Jun. 03, 2021 USD ($)
Schedule of represents the purchase price [Abstract]
Cash and cash equivalents	$ 48,689
Other current assets	13,666,168
Property, plant and equipment	310,631
Current liabilities	(3,697,772)
Total purchase price	$ 10,327,716

XML 52 R41.htm IDEA: XBRL DOCUMENT

Revenue (Details)	Sep. 30, 2021 USD ($)
Revenue from Contract with Customer [Abstract]
Expect to recognize revenue next twelve months	$ 152,039

XML 53 R42.htm IDEA: XBRL DOCUMENT

Revenue (Details) - Schedule of revenue - USD ($)	3 Months Ended		9 Months Ended
Revenue (Details) - Schedule of revenue - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Schedule of revenue [Abstract]
Product sales	$ 3,641,944	$ 459,795	$ 9,078,664	$ 927,889
Franchise fees and income	743,150		889,296
Revenues from transactions with franchisees	10,660,302		18,947,081
Revenue	$ 15,045,396	$ 459,795	$ 28,915,041	$ 927,889

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

XML 54 R43.htm IDEA: XBRL DOCUMENT

Revenue (Details) - Schedule of contract liabilities - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Schedule of contract liabilities [Abstract]
Deferred revenue related to prepaid coffee and wine products	$ 107,221	$ 27,648
Deferred revenue related to upfront franchise fees	152,039
Contract liabilities	$ 259,260	$ 27,648

XML 55 R44.htm IDEA: XBRL DOCUMENT

Inventory (Details) - Schedule of inventory - USD ($)

Sep. 30, 2021

Dec. 31, 2020

Schedule of inventory [Abstract]

Raw materials

^[1]

$ 11,611,690

$ 51,521

Finished goods

182,341

14,516

Inventory, total

$ 11,794,031

$ 66,037

[1]	Raw materials mainly consist of unprocessed coffee tea beans, unprocessed wine and packaging materials

XML 56 R45.htm IDEA: XBRL DOCUMENT

Leasehold Improvement and Equipment, Net (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 31,609	$ 3,555	$ 55,833	$ 17,976

XML 57 R46.htm IDEA: XBRL DOCUMENT

Leasehold Improvement and Equipment, Net (Details) - Schedule of leasehold improvement and equipment, net - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Leasehold improvement and equipment, gross	$ 603,718	$ 141,007
Less: accumulated depreciation	(190,355)	(53,673)
Leasehold improvement and equipment, net	413,363	87,333
Leasehold improvement [Member]
Property, Plant and Equipment [Line Items]
Leasehold improvement and equipment, gross	65,008	64,191
Equipment [Member]
Property, Plant and Equipment [Line Items]
Leasehold improvement and equipment, gross	20,975	16,653
Machinery [Member]
Property, Plant and Equipment [Line Items]
Leasehold improvement and equipment, gross	33,603	32,563
Computer equipment and software [Member]
Property, Plant and Equipment [Line Items]
Leasehold improvement and equipment, gross	41,373	20,355
Motor vehicle [Member]
Property, Plant and Equipment [Line Items]
Leasehold improvement and equipment, gross	$ 442,759	$ 7,245

XML 58 R47.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
Intangible Assets (Details) - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 12,739		$ 14,422	$ 1,628
Impairment loss on intangible assets					$ 76,365

XML 59 R48.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details) - Schedule of intangible assets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Schedule of intangible assets [Abstract]
APP Platform	$ 93,072
Less: accumulated amortization	(14,478)
Intangible assets, net	$ 78,594

XML 60 R49.htm IDEA: XBRL DOCUMENT

Other Payables and Accruals (Details)	Sep. 30, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Number of customers	1	1

XML 61 R50.htm IDEA: XBRL DOCUMENT

Other Payables and Accruals (Details) - Schedule of other payables and accruals - USD ($)

Sep. 30, 2021

Dec. 31, 2020

Schedule of other payables and accruals [Abstract]

Accrued payroll and welfare payable

$ 70,819

$ 180,878

VAT and other taxes payable

786,850

92,608

Others

^[1]

40,849

63,118

Other payables and accruals

$ 898,518

$ 336,604

[1]	As of September 30, 2021 and December 31, 2020, others mainly consist of the outstanding refundable balance upon termination of the cooperative agreement with one customer and payables for rental expenses.

XML 62 R51.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Income Taxes (Details) [Line Items]
Tax loss carried forward (in Dollars)			$ 108,633
Deferred tax assets (in Dollars)	$ 108,633		$ 108,633
Statutory tax rates	25.00%	25.00%	25.00%	25.00%
Hong Kong [Member]
Income Taxes (Details) [Line Items]
Income tax rate			16.50%
PRC [Member]
Income Taxes (Details) [Line Items]
Income tax rate			25.00%

XML 63 R52.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - Schedule of income tax benefits - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Schedule of income tax benefits [Abstract]
Current tax expense	$ 2,456,527		$ 4,799,020
Deferred tax benefits	92,172		(108,215)
Income tax benefits	$ 2,548,699		$ 4,690,805

XML 64 R53.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - Schedule of statutory tax rates - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Schedule of statutory tax rates [Abstract]
Profit (Loss) before tax	$ 9,867,761	$ (351,435)	$ 19,297,550	$ (590,347)
Tax expense (benefit) calculated at statutory tax rate	25.00%	25.00%	25.00%	25.00%
Computed expected tax expense (benefit)	$ 2,466,940	$ (87,859)	$ 4,824,387	$ (147,587)
Utilization of tax loss	(39,633)		(39,633)
Movement in valuation allowance	71,059	87,859	(89,695)	147,587
Others	10,700		(4,254)
Income tax benefits	$ 2,548,699		$ 4,690,805

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

XML 65 R54.htm IDEA: XBRL DOCUMENT

Leases (Details) - USD ($)	3 Months Ended		9 Months Ended
Leases (Details) - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Debt Instrument, Interest Rate, Effective Percentage	4.75%		4.75%
Rent expense	$ 81,135	$ 66,870	$ 240,973	$ 196,005

XML 66 R55.htm IDEA: XBRL DOCUMENT

Leases (Details) - Schedule of future minimum payments under long-term non-cancelable operating leases	Sep. 30, 2021 USD ($)
Schedule of future minimum payments under long-term non-cancelable operating leases [Abstract]
Within 1 year	$ 162,800
After 1 year but within 5 years	22,844
Total lease payments	185,644
Less: imputed interest	(26,112)
Total lease obligations	159,532
Less: current obligations	(139,483)
Long-term lease obligations	$ 20,049

XML 67 R56.htm IDEA: XBRL DOCUMENT

Leases (Details) - Schedule of other information - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases	$ 240,973	$ 196,005
Right-of-use assets obtained in exchange for operating lease liabilities	$ 165,231	$ 291,480
Remaining lease term for operating leases (years)	2 years	3 years
Weighted average discount rate for operating leases	4.75%	4.75%

XML 68 R57.htm IDEA: XBRL DOCUMENT

Related Parties Transactions (Details) - Schedule of amount due from related parties - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Related Parties Transactions (Details) - Schedule of amount due from related parties [Line Items]
Due to related parties	$ 52,762
Total		$ 142,450
Ye Aiyun [Member]
Related Parties Transactions (Details) - Schedule of amount due from related parties [Line Items]
Relationship, description	Shareholder of the Company
Due to related parties
Total		142,450
Shenzhen Weilian Jin Meng Culture Spreading Limited [Member]
Related Parties Transactions (Details) - Schedule of amount due from related parties [Line Items]
Relationship, description	Zhu Hong is the shareholder
Due to related parties	$ 52,762
Total

- Definition

For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.10(3))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(C))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.3)
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

+ Details

- Definition

A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.

+ References + Details

XML 69 R58.htm IDEA: XBRL DOCUMENT

Related Parties Transactions (Details) - Schedule of amount due to related parties - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Related Parties Transactions (Details) - Schedule of amount due to related parties [Line Items]
Total	$ 79,491	$ 1,097,152
Zhu Hong [Member]
Related Parties Transactions (Details) - Schedule of amount due to related parties [Line Items]
Relationship, decription	Shareholder of the Company
Total	$ 79,491	1,059,853
Zhu Jian Yong [Member]
Related Parties Transactions (Details) - Schedule of amount due to related parties [Line Items]
Relationship, decription	Shareholder of the Company
Total		1,731
Shenzhen Weilian Jin Meng Culture Spreading Limited [Member]
Related Parties Transactions (Details) - Schedule of amount due to related parties [Line Items]
Relationship, decription	Zhu Hong is the shareholder
Total		24,800
Shenzhen Nainiang Wine Limited [Member]
Related Parties Transactions (Details) - Schedule of amount due to related parties [Line Items]
Relationship, decription	Zhu Hong is the shareholder
Total		$ 10,768

- Definition

Carrying amount as of the balance sheet date of obligations due all related parties.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(C))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3),(4))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

+ Details

- Definition

+ References + Details

XML 70 R59.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details)	9 Months Ended
Commitments and Contingencies (Details)	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies, description	the US listing with a contract sum of $1,200,000. The outstanding committed contract amount is $120,000. The terms of the agreement are for various milestones stages to be completed within two years through 2021. Future commitments within one year as of September 30, 2021 was $120,000. No future commitments more than one year as of September 30, 2021.

EXCEL 71 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 73 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 86 281 1 true 27 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited) Sheet http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Changes in Equity (Deficit) (Unaudited) Sheet http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Changes in Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Description of Business Sheet http://www.fountainhealthyaging.com/role/DescriptionofBusiness Description of Business Notes 7 false false R8.htm 007 - Disclosure - Basis of Presentation Sheet http://www.fountainhealthyaging.com/role/BasisofPresentation Basis of Presentation Notes 8 false false R9.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Risks and Uncertainties Sheet http://www.fountainhealthyaging.com/role/RisksandUncertainties Risks and Uncertainties Notes 10 false false R11.htm 010 - Disclosure - Business Combination Sheet http://www.fountainhealthyaging.com/role/BusinessCombination Business Combination Notes 11 false false R12.htm 011 - Disclosure - Revenue Sheet http://www.fountainhealthyaging.com/role/Revenue Revenue Notes 12 false false R13.htm 012 - Disclosure - Other Receivables Sheet http://www.fountainhealthyaging.com/role/OtherReceivables Other Receivables Notes 13 false false R14.htm 013 - Disclosure - Inventory Sheet http://www.fountainhealthyaging.com/role/Inventory Inventory Notes 14 false false R15.htm 014 - Disclosure - Prepayment Sheet http://www.fountainhealthyaging.com/role/Prepayment Prepayment Notes 15 false false R16.htm 015 - Disclosure - Leasehold Improvement and Equipment, Net Sheet http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNet Leasehold Improvement and Equipment, Net Notes 16 false false R17.htm 016 - Disclosure - Intangible Assets Sheet http://www.fountainhealthyaging.com/role/IntangibleAssets Intangible Assets Notes 17 false false R18.htm 017 - Disclosure - Other Payables and Accruals Sheet http://www.fountainhealthyaging.com/role/OtherPayablesandAccruals Other Payables and Accruals Notes 18 false false R19.htm 018 - Disclosure - Income Taxes Sheet http://www.fountainhealthyaging.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 019 - Disclosure - Leases Sheet http://www.fountainhealthyaging.com/role/Leases Leases Notes 20 false false R21.htm 020 - Disclosure - Related Parties Transactions Sheet http://www.fountainhealthyaging.com/role/RelatedPartiesTransactions Related Parties Transactions Notes 21 false false R22.htm 021 - Disclosure - Commitments and Contingencies Sheet http://www.fountainhealthyaging.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 22 false false R23.htm 022 - Disclosure - Subsequent Events Sheet http://www.fountainhealthyaging.com/role/SubsequentEvents Subsequent Events Notes 23 false false R24.htm 023 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.fountainhealthyaging.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPolicies 24 false false R25.htm 024 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPolicies 25 false false R26.htm 025 - Disclosure - Business Combination (Tables) Sheet http://www.fountainhealthyaging.com/role/BusinessCombinationTables Business Combination (Tables) Tables http://www.fountainhealthyaging.com/role/BusinessCombination 26 false false R27.htm 026 - Disclosure - Revenue (Tables) Sheet http://www.fountainhealthyaging.com/role/RevenueTables Revenue (Tables) Tables http://www.fountainhealthyaging.com/role/Revenue 27 false false R28.htm 027 - Disclosure - Inventory (Tables) Sheet http://www.fountainhealthyaging.com/role/InventoryTables Inventory (Tables) Tables http://www.fountainhealthyaging.com/role/Inventory 28 false false R29.htm 028 - Disclosure - Leasehold Improvement and Equipment, Net (Tables) Sheet http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetTables Leasehold Improvement and Equipment, Net (Tables) Tables http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNet 29 false false R30.htm 029 - Disclosure - Intangible Assets (Tables) Sheet http://www.fountainhealthyaging.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.fountainhealthyaging.com/role/IntangibleAssets 30 false false R31.htm 030 - Disclosure - Other Payables and Accruals (Tables) Sheet http://www.fountainhealthyaging.com/role/OtherPayablesandAccrualsTables Other Payables and Accruals (Tables) Tables http://www.fountainhealthyaging.com/role/OtherPayablesandAccruals 31 false false R32.htm 031 - Disclosure - Income Taxes (Tables) Sheet http://www.fountainhealthyaging.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.fountainhealthyaging.com/role/IncomeTaxes 32 false false R33.htm 032 - Disclosure - Leases (Tables) Sheet http://www.fountainhealthyaging.com/role/LeasesTables Leases (Tables) Tables http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNet 33 false false R34.htm 033 - Disclosure - Related Parties Transactions (Tables) Sheet http://www.fountainhealthyaging.com/role/RelatedPartiesTransactionsTables Related Parties Transactions (Tables) Tables http://www.fountainhealthyaging.com/role/RelatedPartiesTransactions 34 false false R35.htm 034 - Disclosure - Description of Business (Details) Sheet http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails Description of Business (Details) Details http://www.fountainhealthyaging.com/role/DescriptionofBusiness 35 false false R36.htm 035 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesTables 36 false false R37.htm 036 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of accounts receivable Sheet http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable Summary of Significant Accounting Policies (Details) - Schedule of accounts receivable Details http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesTables 37 false false R38.htm 037 - Disclosure - Risks and Uncertainties (Details) Sheet http://www.fountainhealthyaging.com/role/RisksandUncertaintiesDetails Risks and Uncertainties (Details) Details http://www.fountainhealthyaging.com/role/RisksandUncertainties 38 false false R39.htm 038 - Disclosure - Business Combination (Details) Sheet http://www.fountainhealthyaging.com/role/BusinessCombinationDetails Business Combination (Details) Details http://www.fountainhealthyaging.com/role/BusinessCombinationTables 39 false false R40.htm 039 - Disclosure - Business Combination (Details) - Schedule of represents the purchase price Sheet http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable Business Combination (Details) - Schedule of represents the purchase price Details http://www.fountainhealthyaging.com/role/BusinessCombinationTables 40 false false R41.htm 040 - Disclosure - Revenue (Details) Sheet http://www.fountainhealthyaging.com/role/RevenueDetails Revenue (Details) Details http://www.fountainhealthyaging.com/role/RevenueTables 41 false false R42.htm 041 - Disclosure - Revenue (Details) - Schedule of revenue Sheet http://www.fountainhealthyaging.com/role/ScheduleofrevenueTable Revenue (Details) - Schedule of revenue Details http://www.fountainhealthyaging.com/role/RevenueTables 42 false false R43.htm 042 - Disclosure - Revenue (Details) - Schedule of contract liabilities Sheet http://www.fountainhealthyaging.com/role/ScheduleofcontractliabilitiesTable Revenue (Details) - Schedule of contract liabilities Details http://www.fountainhealthyaging.com/role/RevenueTables 43 false false R44.htm 043 - Disclosure - Inventory (Details) - Schedule of inventory Sheet http://www.fountainhealthyaging.com/role/ScheduleofinventoryTable Inventory (Details) - Schedule of inventory Details http://www.fountainhealthyaging.com/role/InventoryTables 44 false false R45.htm 044 - Disclosure - Leasehold Improvement and Equipment, Net (Details) Sheet http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetDetails Leasehold Improvement and Equipment, Net (Details) Details http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetTables 45 false false R46.htm 045 - Disclosure - Leasehold Improvement and Equipment, Net (Details) - Schedule of leasehold improvement and equipment, net Sheet http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable Leasehold Improvement and Equipment, Net (Details) - Schedule of leasehold improvement and equipment, net Details http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetTables 46 false false R47.htm 046 - Disclosure - Intangible Assets (Details) Sheet http://www.fountainhealthyaging.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://www.fountainhealthyaging.com/role/IntangibleAssetsTables 47 false false R48.htm 047 - Disclosure - Intangible Assets (Details) - Schedule of intangible assets Sheet http://www.fountainhealthyaging.com/role/ScheduleofintangibleassetsTable Intangible Assets (Details) - Schedule of intangible assets Details http://www.fountainhealthyaging.com/role/IntangibleAssetsTables 48 false false R49.htm 048 - Disclosure - Other Payables and Accruals (Details) Sheet http://www.fountainhealthyaging.com/role/OtherPayablesandAccrualsDetails Other Payables and Accruals (Details) Details http://www.fountainhealthyaging.com/role/OtherPayablesandAccrualsTables 49 false false R50.htm 049 - Disclosure - Other Payables and Accruals (Details) - Schedule of other payables and accruals Sheet http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable Other Payables and Accruals (Details) - Schedule of other payables and accruals Details http://www.fountainhealthyaging.com/role/OtherPayablesandAccrualsTables 50 false false R51.htm 050 - Disclosure - Income Taxes (Details) Sheet http://www.fountainhealthyaging.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.fountainhealthyaging.com/role/IncomeTaxesTables 51 false false R52.htm 051 - Disclosure - Income Taxes (Details) - Schedule of income tax benefits Sheet http://www.fountainhealthyaging.com/role/ScheduleofincometaxbenefitsTable Income Taxes (Details) - Schedule of income tax benefits Details http://www.fountainhealthyaging.com/role/IncomeTaxesTables 52 false false R53.htm 052 - Disclosure - Income Taxes (Details) - Schedule of statutory tax rates Sheet http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable Income Taxes (Details) - Schedule of statutory tax rates Details http://www.fountainhealthyaging.com/role/IncomeTaxesTables 53 false false R54.htm 053 - Disclosure - Leases (Details) Sheet http://www.fountainhealthyaging.com/role/LeasesDetails Leases (Details) Details http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetTables 54 false false R55.htm 054 - Disclosure - Leases (Details) - Schedule of future minimum payments under long-term non-cancelable operating leases Sheet http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable Leases (Details) - Schedule of future minimum payments under long-term non-cancelable operating leases Details http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetTables 55 false false R56.htm 055 - Disclosure - Leases (Details) - Schedule of other information Sheet http://www.fountainhealthyaging.com/role/ScheduleofotherinformationTable Leases (Details) - Schedule of other information Details http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetTables 56 false false R57.htm 056 - Disclosure - Related Parties Transactions (Details) - Schedule of amount due from related parties Sheet http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable Related Parties Transactions (Details) - Schedule of amount due from related parties Details http://www.fountainhealthyaging.com/role/RelatedPartiesTransactionsTables 57 false false R58.htm 057 - Disclosure - Related Parties Transactions (Details) - Schedule of amount due to related parties Sheet http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable Related Parties Transactions (Details) - Schedule of amount due to related parties Details http://www.fountainhealthyaging.com/role/RelatedPartiesTransactionsTables 58 false false R59.htm 058 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.fountainhealthyaging.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.fountainhealthyaging.com/role/CommitmentsandContingencies 59 false false All Reports Book All Reports f10q0921_fountainhealthy.htm f10q0921ex31-1_fountain.htm f10q0921ex31-2_fountain.htm f10q0921ex32-1_fountain.htm f10q0921ex32-2_fountain.htm fhai-20210930.xsd fhai-20210930_cal.xml fhai-20210930_def.xml fhai-20210930_lab.xml fhai-20210930_pre.xml http://xbrl.sec.gov/country/2021 http://xbrl.sec.gov/sic/2021 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 true true JSON 76 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0921_fountainhealthy.htm": { "axisCustom": 0, "axisStandard": 10, "contextCount": 86, "dts": { "calculationLink": { "local": [ "fhai-20210930_cal.xml" ] }, "definitionLink": { "local": [ "fhai-20210930_def.xml" ] }, "inline": { "local": [ "f10q0921_fountainhealthy.htm" ] }, "labelLink": { "local": [ "fhai-20210930_lab.xml" ] }, "presentationLink": { "local": [ "fhai-20210930_pre.xml" ] }, "schema": { "local": [ "fhai-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 325, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 47, "http://www.fountainhealthyaging.com/20210930": 5, "http://xbrl.sec.gov/dei/2021": 5, "total": 57 }, "keyCustom": 21, "keyStandard": 260, "memberCustom": 11, "memberStandard": 16, "nsprefix": "fhai", "nsuri": "http://www.fountainhealthyaging.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Risks and Uncertainties", "role": "http://www.fountainhealthyaging.com/role/RisksandUncertainties", "shortName": "Risks and Uncertainties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Business Combination", "role": "http://www.fountainhealthyaging.com/role/BusinessCombination", "shortName": "Business Combination", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Revenue", "role": "http://www.fountainhealthyaging.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Other Receivables", "role": "http://www.fountainhealthyaging.com/role/OtherReceivables", "shortName": "Other Receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Inventory", "role": "http://www.fountainhealthyaging.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Prepayment", "role": "http://www.fountainhealthyaging.com/role/Prepayment", "shortName": "Prepayment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Leasehold Improvement and Equipment, Net", "role": "http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNet", "shortName": "Leasehold Improvement and Equipment, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Intangible Assets", "role": "http://www.fountainhealthyaging.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Other Payables and Accruals", "role": "http://www.fountainhealthyaging.com/role/OtherPayablesandAccruals", "shortName": "Other Payables and Accruals", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Income Taxes", "role": "http://www.fountainhealthyaging.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Leases", "role": "http://www.fountainhealthyaging.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Related Parties Transactions", "role": "http://www.fountainhealthyaging.com/role/RelatedPartiesTransactions", "shortName": "Related Parties Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Commitments and Contingencies", "role": "http://www.fountainhealthyaging.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Subsequent Events", "role": "http://www.fountainhealthyaging.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://www.fountainhealthyaging.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Business Combination (Tables)", "role": "http://www.fountainhealthyaging.com/role/BusinessCombinationTables", "shortName": "Business Combination (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Revenue (Tables)", "role": "http://www.fountainhealthyaging.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Inventory (Tables)", "role": "http://www.fountainhealthyaging.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Leasehold Improvement and Equipment, Net (Tables)", "role": "http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetTables", "shortName": "Leasehold Improvement and Equipment, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Intangible Assets (Tables)", "role": "http://www.fountainhealthyaging.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Other Payables and Accruals (Tables)", "role": "http://www.fountainhealthyaging.com/role/OtherPayablesandAccrualsTables", "shortName": "Other Payables and Accruals (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Income Taxes (Tables)", "role": "http://www.fountainhealthyaging.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Leases (Tables)", "role": "http://www.fountainhealthyaging.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "fhai:ScheduleOfAmountDueFromRelatedPartiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Related Parties Transactions (Tables)", "role": "http://www.fountainhealthyaging.com/role/RelatedPartiesTransactionsTables", "shortName": "Related Parties Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "fhai:ScheduleOfAmountDueFromRelatedPartiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c47", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Description of Business (Details)", "role": "http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails", "shortName": "Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c47", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "fhai:AgreementTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "fhai:AgreementTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableSale", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of accounts receivable", "role": "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of accounts receivable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableSale", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c51", "decimals": "2", "first": true, "lang": null, "name": "fhai:ConcentrationRiskThresholdPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Risks and Uncertainties (Details)", "role": "http://www.fountainhealthyaging.com/role/RisksandUncertaintiesDetails", "shortName": "Risks and Uncertainties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c51", "decimals": "2", "first": true, "lang": null, "name": "fhai:ConcentrationRiskThresholdPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c53", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Business Combination (Details)", "role": "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails", "shortName": "Business Combination (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c53", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited)", "role": "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c57", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Business Combination (Details) - Schedule of represents the purchase price", "role": "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable", "shortName": "Business Combination (Details) - Schedule of represents the purchase price", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c57", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "fhai:ExpectsToRecognizeRevenueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Revenue (Details)", "role": "http://www.fountainhealthyaging.com/role/RevenueDetails", "shortName": "Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "fhai:ExpectsToRecognizeRevenueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "fhai:ProductSales", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Revenue (Details) - Schedule of revenue", "role": "http://www.fountainhealthyaging.com/role/ScheduleofrevenueTable", "shortName": "Revenue (Details) - Schedule of revenue", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "fhai:ProductSales", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "fhai:ScheduleOfContractLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "fhai:DeferredRevenueRelatedToPrepaidWineProducts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Revenue (Details) - Schedule of contract liabilities", "role": "http://www.fountainhealthyaging.com/role/ScheduleofcontractliabilitiesTable", "shortName": "Revenue (Details) - Schedule of contract liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "fhai:ScheduleOfContractLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "fhai:DeferredRevenueRelatedToPrepaidWineProducts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Inventory (Details) - Schedule of inventory", "role": "http://www.fountainhealthyaging.com/role/ScheduleofinventoryTable", "shortName": "Inventory (Details) - Schedule of inventory", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Leasehold Improvement and Equipment, Net (Details)", "role": "http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetDetails", "shortName": "Leasehold Improvement and Equipment, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Leasehold Improvement and Equipment, Net (Details) - Schedule of leasehold improvement and equipment, net", "role": "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable", "shortName": "Leasehold Improvement and Equipment, Net (Details) - Schedule of leasehold improvement and equipment, net", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Intangible Assets (Details)", "role": "http://www.fountainhealthyaging.com/role/IntangibleAssetsDetails", "shortName": "Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Intangible Assets (Details) - Schedule of intangible assets", "role": "http://www.fountainhealthyaging.com/role/ScheduleofintangibleassetsTable", "shortName": "Intangible Assets (Details) - Schedule of intangible assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "fhai:NumberOfCustomers", "span", "link:footnote", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "fhai:NumberOfCustomers", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Other Payables and Accruals (Details)", "role": "http://www.fountainhealthyaging.com/role/OtherPayablesandAccrualsDetails", "shortName": "Other Payables and Accruals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "fhai:NumberOfCustomers", "span", "link:footnote", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "fhai:NumberOfCustomers", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Changes in Equity (Deficit) (Unaudited)", "role": "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Consolidated Statements of Changes in Equity (Deficit) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Other Payables and Accruals (Details) - Schedule of other payables and accruals", "role": "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable", "shortName": "Other Payables and Accruals (Details) - Schedule of other payables and accruals", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "fhai:TaxLossCarriedForward", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Income Taxes (Details)", "role": "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "fhai:TaxLossCarriedForward", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - Income Taxes (Details) - Schedule of income tax benefits", "role": "http://www.fountainhealthyaging.com/role/ScheduleofincometaxbenefitsTable", "shortName": "Income Taxes (Details) - Schedule of income tax benefits", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - Income Taxes (Details) - Schedule of statutory tax rates", "role": "http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable", "shortName": "Income Taxes (Details) - Schedule of statutory tax rates", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "2", "lang": null, "name": "fhai:TaxExpensebenefitsCalculatedAtStatutoryTaxRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "reportCount": 1, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - Leases (Details)", "role": "http://www.fountainhealthyaging.com/role/LeasesDetails", "shortName": "Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c6", "decimals": "0", "lang": null, "name": "us-gaap:LeaseAndRentalExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - Leases (Details) - Schedule of future minimum payments under long-term non-cancelable operating leases", "role": "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable", "shortName": "Leases (Details) - Schedule of future minimum payments under long-term non-cancelable operating leases", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "fhai:OtherInformationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "055 - Disclosure - Leases (Details) - Schedule of other information", "role": "http://www.fountainhealthyaging.com/role/ScheduleofotherinformationTable", "shortName": "Leases (Details) - Schedule of other information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "fhai:OtherInformationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "fhai:ScheduleOfAmountDueFromRelatedPartiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "056 - Disclosure - Related Parties Transactions (Details) - Schedule of amount due from related parties", "role": "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable", "shortName": "Related Parties Transactions (Details) - Schedule of amount due from related parties", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "fhai:ScheduleOfAmountDueFromRelatedPartiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "fhai:ScheduleOfAmountDueToRelatedPartiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "057 - Disclosure - Related Parties Transactions (Details) - Schedule of amount due to related parties", "role": "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable", "shortName": "Related Parties Transactions (Details) - Schedule of amount due to related parties", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "fhai:ScheduleOfAmountDueToRelatedPartiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCommitmentsDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "058 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.fountainhealthyaging.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCommitmentsDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Description of Business", "role": "http://www.fountainhealthyaging.com/role/DescriptionofBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Basis of Presentation", "role": "http://www.fountainhealthyaging.com/role/BasisofPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_fountainhealthy.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 27, "tag": { "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHINA", "terseLabel": "PRC [Member]" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "country_HK": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "HONG KONG", "terseLabel": "Hong Kong [Member]" } } }, "localname": "HK", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "fhai_AccountsReceivablePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AccountsReceivablePercentage", "terseLabel": "Accounts receivable percentage" } } }, "localname": "AccountsReceivablePercentage", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable" ], "xbrltype": "percentItemType" }, "fhai_AdvanceToSuppliers": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of advance to suppliers.", "label": "AdvanceToSuppliers", "terseLabel": "Advance to suppliers" } } }, "localname": "AdvanceToSuppliers", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "fhai_AdvanceToSuppliersPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AdvanceToSuppliersPolicyTextBlock", "terseLabel": "Advance to suppliers" } } }, "localname": "AdvanceToSuppliersPolicyTextBlock", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "fhai_AgreementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AgreementTerm", "terseLabel": "Agreement term" } } }, "localname": "AgreementTerm", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "fhai_BusinessCombinationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Line Items]" } } }, "localname": "BusinessCombinationDetailsLineItems", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "fhai_BusinessCombinationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Table]" } } }, "localname": "BusinessCombinationDetailsTable", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "fhai_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherinformationTable" ], "xbrltype": "stringItemType" }, "fhai_ConcentrationRiskThresholdPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConcentrationRiskThresholdPercentage", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskThresholdPercentage", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/RisksandUncertaintiesDetails" ], "xbrltype": "percentItemType" }, "fhai_CustomerAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CustomerAMember", "terseLabel": "Customer A [Member]" } } }, "localname": "CustomerAMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable" ], "xbrltype": "domainItemType" }, "fhai_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CustomerBMember", "terseLabel": "Customer B [Member]" } } }, "localname": "CustomerBMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable" ], "xbrltype": "domainItemType" }, "fhai_DeferredRevenueRelatedToPrepaidWineProducts": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofcontractliabilitiesTable": { "order": 1.0, "parentTag": "us-gaap_ContractWithCustomerLiabilityCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue related to prepaid wine products.", "label": "DeferredRevenueRelatedToPrepaidWineProducts", "terseLabel": "Deferred revenue related to prepaid coffee and wine products" } } }, "localname": "DeferredRevenueRelatedToPrepaidWineProducts", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofcontractliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "fhai_DeferredRevenueRelatedToUpfrontFranchiseFees": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofcontractliabilitiesTable": { "order": 2.0, "parentTag": "us-gaap_ContractWithCustomerLiabilityCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue related to upfront franchise fees.", "label": "DeferredRevenueRelatedToUpfrontFranchiseFees", "terseLabel": "Deferred revenue related to upfront franchise fees" } } }, "localname": "DeferredRevenueRelatedToUpfrontFranchiseFees", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofcontractliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "fhai_DescriptionofBusinessDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Business (Details) [Line Items]" } } }, "localname": "DescriptionofBusinessDetailsLineItems", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "fhai_DescriptionofBusinessDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Business (Details) [Table]" } } }, "localname": "DescriptionofBusinessDetailsTable", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "fhai_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ExpectsToRecognizeRevenueNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ExpectsToRecognizeRevenueNextTwelveMonths", "terseLabel": "Expect to recognize revenue next twelve months" } } }, "localname": "ExpectsToRecognizeRevenueNextTwelveMonths", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/RevenueDetails" ], "xbrltype": "monetaryItemType" }, "fhai_FHAIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FHAIMember", "terseLabel": "FHAI [Member]" } } }, "localname": "FHAIMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "fhai_FranchiseFeesAndIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "FranchiseFeesAndIncome", "terseLabel": "Franchise fees and income" } } }, "localname": "FranchiseFeesAndIncome", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofrevenueTable" ], "xbrltype": "monetaryItemType" }, "fhai_IncomeTaxBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax benefits.", "label": "IncomeTaxBenefit", "terseLabel": "Income tax benefits" } } }, "localname": "IncomeTaxBenefit", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofincometaxbenefitsTable" ], "xbrltype": "monetaryItemType" }, "fhai_IncomeTaxesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) [Line Items]" } } }, "localname": "IncomeTaxesDetailsLineItems", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "fhai_IncomeTaxesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) [Table]" } } }, "localname": "IncomeTaxesDetailsTable", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "fhai_MovementInValuationAllowance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Movement in valuation allowance", "label": "MovementInValuationAllowance", "terseLabel": "Movement in valuation allowance" } } }, "localname": "MovementInValuationAllowance", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable" ], "xbrltype": "monetaryItemType" }, "fhai_MsZhuHongAsMsZhuHongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MsZhuHongAsMsZhuHongMember", "terseLabel": "Ms. Zhu Hong, as Ms. Zhu Hong [Member]" } } }, "localname": "MsZhuHongAsMsZhuHongMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "fhai_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of customers.", "label": "NumberOfCustomers", "terseLabel": "Number of customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/OtherPayablesandAccrualsDetails" ], "xbrltype": "integerItemType" }, "fhai_OperatingLeaseCurrentObligation": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable": { "order": 3.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating leasecurrent obligation.", "label": "OperatingLeaseCurrentObligation", "negatedLabel": "Less: current obligations" } } }, "localname": "OperatingLeaseCurrentObligation", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "fhai_OtherInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OtherInformationTableTextBlock", "terseLabel": "Schedule of other information" } } }, "localname": "OtherInformationTableTextBlock", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "fhai_ProductSales": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Product sales", "label": "ProductSales", "terseLabel": "Product sales" } } }, "localname": "ProductSales", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofrevenueTable" ], "xbrltype": "monetaryItemType" }, "fhai_RelatedPartiesTransactionsDetailsScheduleofamountduefromrelatedpartiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties Transactions (Details) - Schedule of amount due from related parties [Line Items]" } } }, "localname": "RelatedPartiesTransactionsDetailsScheduleofamountduefromrelatedpartiesLineItems", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable" ], "xbrltype": "stringItemType" }, "fhai_RelatedPartiesTransactionsDetailsScheduleofamountduefromrelatedpartiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties Transactions (Details) - Schedule of amount due from related parties [Table]" } } }, "localname": "RelatedPartiesTransactionsDetailsScheduleofamountduefromrelatedpartiesTable", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable" ], "xbrltype": "stringItemType" }, "fhai_RelatedPartiesTransactionsDetailsScheduleofamountduetorelatedpartiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties Transactions (Details) - Schedule of amount due to related parties [Line Items]" } } }, "localname": "RelatedPartiesTransactionsDetailsScheduleofamountduetorelatedpartiesLineItems", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "stringItemType" }, "fhai_RelatedPartiesTransactionsDetailsScheduleofamountduetorelatedpartiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties Transactions (Details) - Schedule of amount due to related parties [Table]" } } }, "localname": "RelatedPartiesTransactionsDetailsScheduleofamountduetorelatedpartiesTable", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "stringItemType" }, "fhai_RightofuseAssetsObtainedInExchangeForOperatingLeaseObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount is right-of-use assets obtained in exchange for operating lease obligations.", "label": "RightofuseAssetsObtainedInExchangeForOperatingLeaseObligations", "terseLabel": "Right-of-use assets obtained in exchange for operating lease obligations" } } }, "localname": "RightofuseAssetsObtainedInExchangeForOperatingLeaseObligations", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "fhai_RisksandUncertaintiesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties (Details) [Line Items]" } } }, "localname": "RisksandUncertaintiesDetailsLineItems", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/RisksandUncertaintiesDetails" ], "xbrltype": "stringItemType" }, "fhai_RisksandUncertaintiesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties (Details) [Table]" } } }, "localname": "RisksandUncertaintiesDetailsTable", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/RisksandUncertaintiesDetails" ], "xbrltype": "stringItemType" }, "fhai_ScheduleOfAccountsReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of accounts receivable [Abstract]" } } }, "localname": "ScheduleOfAccountsReceivableAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfAmountDueFromRelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of amount due from related parties [Abstract]" } } }, "localname": "ScheduleOfAmountDueFromRelatedPartiesAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfAmountDueFromRelatedPartiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfAmountDueFromRelatedPartiesTableTextBlock", "terseLabel": "Schedule of amount due from related parties" } } }, "localname": "ScheduleOfAmountDueFromRelatedPartiesTableTextBlock", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/RelatedPartiesTransactionsTables" ], "xbrltype": "textBlockItemType" }, "fhai_ScheduleOfAmountDueToRelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of amount due to related parties [Abstract]" } } }, "localname": "ScheduleOfAmountDueToRelatedPartiesAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfAmountDueToRelatedPartiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfAmountDueToRelatedPartiesTableTextBlock", "terseLabel": "Schedule of amount due to related parties" } } }, "localname": "ScheduleOfAmountDueToRelatedPartiesTableTextBlock", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/RelatedPartiesTransactionsTables" ], "xbrltype": "textBlockItemType" }, "fhai_ScheduleOfContractLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of contract liabilities [Abstract]" } } }, "localname": "ScheduleOfContractLiabilitiesAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfContractLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfContractLiabilitiesTableTextBlock", "terseLabel": "Schedule of contract liabilities" } } }, "localname": "ScheduleOfContractLiabilitiesTableTextBlock", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "fhai_ScheduleOfFutureMinimumPaymentsUnderLongTermNonCancelableOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of future minimum payments under long-term non-cancelable operating leases [Abstract]" } } }, "localname": "ScheduleOfFutureMinimumPaymentsUnderLongTermNonCancelableOperatingLeasesAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfIncomeTaxBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of income tax benefits [Abstract]" } } }, "localname": "ScheduleOfIncomeTaxBenefitsAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of intangible assets [Abstract]" } } }, "localname": "ScheduleOfIntangibleAssetsAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfInventoryAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of inventory [Abstract]" } } }, "localname": "ScheduleOfInventoryAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfLeaseholdImprovementAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of leasehold improvement and equipment, net [Abstract]" } } }, "localname": "ScheduleOfLeaseholdImprovementAndEquipmentNetAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfOtherInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of other information [Abstract]" } } }, "localname": "ScheduleOfOtherInformationAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfOtherPayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of other payables and accruals [Abstract]" } } }, "localname": "ScheduleOfOtherPayablesAndAccrualsAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfRepresentsThePurchasePriceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of represents the purchase price [Abstract]" } } }, "localname": "ScheduleOfRepresentsThePurchasePriceAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of revenue [Abstract]" } } }, "localname": "ScheduleOfRevenueAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ScheduleOfStatutoryTaxRatesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of statutory tax rates [Abstract]" } } }, "localname": "ScheduleOfStatutoryTaxRatesAbstract", "nsuri": "http://www.fountainhealthyaging.com/20210930", "xbrltype": "stringItemType" }, "fhai_ShenzhenNainiangWineLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ShenzhenNainiangWineLimitedMember", "terseLabel": "Shenzhen Nainiang Wine Limited [Member]" } } }, "localname": "ShenzhenNainiangWineLimitedMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "domainItemType" }, "fhai_ShenzhenWeiLianMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ShenzhenWeiLianMember", "terseLabel": "Shenzhen Wei Lian [Member]" } } }, "localname": "ShenzhenWeiLianMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "fhai_ShenzhenWeilianJinMengCultureSpreadingLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ShenzhenWeilianJinMengCultureSpreadingLimitedMember", "terseLabel": "Shenzhen Weilian Jin Meng Culture Spreading Limited\t[Member]" } } }, "localname": "ShenzhenWeilianJinMengCultureSpreadingLimitedMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable", "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "domainItemType" }, "fhai_ShenzhensWeiLianMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ShenzhensWeiLianMember", "terseLabel": "Shenzhen Wei Lian [Member]" } } }, "localname": "ShenzhensWeiLianMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "fhai_TaxExpensebenefitsCalculatedAtStatutoryTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TaxExpensebenefitsCalculatedAtStatutoryTaxRate", "terseLabel": "Tax expense (benefit) calculated at statutory tax rate" } } }, "localname": "TaxExpensebenefitsCalculatedAtStatutoryTaxRate", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable" ], "xbrltype": "percentItemType" }, "fhai_TaxLossCarriedForward": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax loss carried forward.", "label": "TaxLossCarriedForward", "terseLabel": "Tax loss carried forward (in Dollars)" } } }, "localname": "TaxLossCarriedForward", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "fhai_YeAiyunMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "YeAiyunMember", "terseLabel": "Ye Aiyun [Member]" } } }, "localname": "YeAiyunMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable" ], "xbrltype": "domainItemType" }, "fhai_ZhuHongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZhuHongMember", "terseLabel": "Zhu Hong [Member]" } } }, "localname": "ZhuHongMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "domainItemType" }, "fhai_ZhuJianYongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZhuJianYongMember", "terseLabel": "Zhu Jian Yong\t[Member]" } } }, "localname": "ZhuJianYongMember", "nsuri": "http://www.fountainhealthyaging.com/20210930", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "domainItemType" }, "sic_Z3570": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "3570 Computer and office Equipment [Member]", "terseLabel": "Computer equipment and software\t[Member]" } } }, "localname": "Z3570", "nsuri": "http://xbrl.sec.gov/sic/2021", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r160", "r229", "r233", "r379" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r160", "r229", "r233", "r379" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.", "label": "Condensed Income Statement [Table Text Block]", "terseLabel": "Schedule of revenue" } } }, "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r158", "r159", "r229", "r232", "r378", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r407", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r158", "r159", "r229", "r232", "r378", "r387", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r407", "r408" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r161", "r327" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "OTHER PAYABLES AND ACCRUALS" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/OtherPayablesandAccruals" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.", "label": "Accounts Payable and Other Accrued Liabilities", "totalLabel": "Other payables and accruals" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable and Other Accrued Liabilities, Current", "terseLabel": "Other payables and accruals" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r49", "r333" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r32", "r162", "r163" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableSale": { "auth_ref": [ "r176" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease from sale of accounts receivable.", "label": "Accounts Receivable, Sale", "terseLabel": "Accounts receivable amount" } } }, "localname": "AccountsReceivableSale", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r11", "r52", "r243" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Taxes Other than Income Taxes, Current", "terseLabel": "VAT and other taxes payable" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r25", "r353", "r365" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income tax payables" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r48", "r189" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r36", "r64", "r65", "r66", "r366", "r384", "r385" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Foreign currency translation reserves" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r63", "r66", "r72", "r73", "r74", "r104", "r105", "r106", "r284", "r380", "r381", "r419" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Reserve" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r33", "r242", "r333" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r104", "r105", "r106", "r239", "r240", "r241", "r290" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments for:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r90", "r179", "r183" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r90", "r186" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment of intangible assets" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r98", "r146", "r149", "r155", "r174", "r198", "r199", "r200", "r202", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r280", "r285", "r295", "r331", "r333", "r352", "r364" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r8", "r61", "r98", "r174", "r198", "r199", "r200", "r202", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r280", "r285", "r295", "r331", "r333" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r17", "r18", "r19", "r20", "r21", "r22", "r23", "r24", "r98", "r174", "r198", "r199", "r200", "r202", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r280", "r285", "r295", "r331" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current assets:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r237", "r238", "r272", "r273" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Shares issued (in Shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of acquisition" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "BUSINESS COMBINATION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r275" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r275" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r275" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "negatedLabel": "Current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r274", "r275" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, plant and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r275" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "totalLabel": "Total purchase price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofrepresentsthepurchasepriceTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationSegmentAllocationTableTextBlock": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill in a business combination.", "label": "Business Combination, Segment Allocation [Table Text Block]", "terseLabel": "Schedule of represents the purchase price" } } }, "localname": "BusinessCombinationSegmentAllocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r103", "r141" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "BASIS OF PRESENTATION" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r46", "r92" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at the end of the year", "periodStartLabel": "Cash and cash equivalents at the beginning of year", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet", "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r87", "r296" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r97", "r98", "r119", "r120", "r121", "r123", "r125", "r129", "r130", "r131", "r174", "r198", "r203", "r204", "r205", "r209", "r210", "r213", "r214", "r215", "r216", "r295", "r405" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r55", "r195", "r357", "r370" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r192", "r193", "r194", "r196", "r389" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r104", "r105", "r290" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r30", "r217" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r30", "r333" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r68", "r70", "r71", "r78", "r360", "r374" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total comprehensive income (loss) for the period" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r136", "r137", "r160", "r293", "r294", "r386", "r388" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/RisksandUncertaintiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "RISKS AND UNCERTAINTIES" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/RisksandUncertainties" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r219", "r220", "r230" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofcontractliabilitiesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "totalLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofcontractliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r81", "r98", "r174", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r295" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "negatedLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r99", "r254", "r262", "r264" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Current tax expense" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofincometaxbenefitsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r54", "r211", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/LeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r245", "r246" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r90", "r99", "r255", "r262", "r263", "r264" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred tax benefits" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofincometaxbenefitsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r40" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r252", "r253" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "negatedLabel": "Utilization of tax loss" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements": { "auth_ref": [ "r252", "r253" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the estimated loss from legal settlements.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements", "terseLabel": "Deferred tax assets (in Dollars)" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r90", "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r90", "r144" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r102", "r201", "r203", "r204", "r208", "r209", "r210", "r326", "r355", "r372" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Due from Related Parties", "terseLabel": "Due to related parties" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedPartiesCurrent": { "auth_ref": [ "r6", "r18", "r31", "r102", "r201", "r203", "r204", "r208", "r209", "r210", "r326" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).", "label": "Due from Related Parties, Current", "terseLabel": "Amount due from related parties" } } }, "localname": "DueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToOtherRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r49", "r102", "r326" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.", "label": "Due to Other Related Parties, Current", "terseLabel": "Total" } } }, "localname": "DueToOtherRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r49", "r102", "r201", "r203", "r204", "r208", "r209", "r210", "r326" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Amount due to related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r102", "r201", "r203", "r204", "r208", "r209", "r210", "r326", "r356", "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "terseLabel": "Total" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r79", "r109", "r110", "r111", "r112", "r113", "r117", "r119", "r123", "r124", "r125", "r126", "r127", "r291", "r292", "r361", "r375" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "- Basic (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic, Other Disclosures [Abstract]", "terseLabel": "Weighted average number of shares used in computation:" } } }, "localname": "EarningsPerShareBasicOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r79", "r109", "r110", "r111", "r112", "r113", "r119", "r123", "r124", "r125", "r126", "r127", "r291", "r292", "r361", "r375" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "- Diluted (in Dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r296" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r100", "r248", "r265" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory tax rates" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued payroll and welfare payable" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r72", "r73", "r74", "r104", "r105", "r106", "r108", "r114", "r116", "r128", "r175", "r217", "r218", "r239", "r240", "r241", "r258", "r259", "r290", "r297", "r298", "r299", "r300", "r301", "r302", "r380", "r381", "r382", "r419" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Percentage of ownership" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r99", "r247" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.", "label": "Federal Income Tax Expense (Benefit), Continuing Operations", "terseLabel": "Income tax benefits" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivablesTextBlock": { "auth_ref": [ "r170", "r172" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financing receivable.", "label": "Financing Receivables [Text Block]", "terseLabel": "OTHER RECEIVABLES" } } }, "localname": "FinancingReceivablesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/OtherReceivables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r182" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofintangibleassetsTable": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Less: accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofintangibleassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r182", "r338" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofintangibleassetsTable": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "APP Platform" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofintangibleassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r82" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "negatedLabel": "General and administrative expense" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r80", "r98", "r146", "r148", "r151", "r154", "r156", "r174", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r295" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_HealthCareOrganizationAllowanceForDoubtfulAccountsPercentageOfAccountsReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio of the allowance for doubtful accounts to accounts receivable, expressed as a percentage, for health care organizations.", "label": "Health Care Organization, Allowance for Doubtful Accounts, Percentage of Accounts Receivable", "terseLabel": "Percentage of accounts receivable" } } }, "localname": "HealthCareOrganizationAllowanceForDoubtfulAccountsPercentageOfAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r90", "r184" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment loss on intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r76", "r146", "r148", "r151", "r154", "r156", "r351", "r358", "r362", "r376" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Profit (Loss) before tax", "totalLabel": "Profit (Loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement", "http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r100", "r249", "r250", "r251", "r260", "r266", "r268", "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r101", "r115", "r116", "r145", "r247", "r261", "r267", "r377" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants": { "auth_ref": [ "r256" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax (expense) benefit from continuing operations attributable to government grants to the extent recognized as a reduction of income tax expense.", "label": "Income Tax (Expense) Benefit, Continuing Operations, Government Grants", "terseLabel": "Computed expected tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income tax paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r89" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r89" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income tax payables" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r89" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Accounts payable, other payables and accruals" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r89", "r336" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Advance to suppliers" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r89" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedLabel": "Deferred tax assets" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r89" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r89" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties", "terseLabel": "Amount due from/to related parties" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r89" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r89" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Other receivables and prepayment" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r178", "r181" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://www.fountainhealthyaging.com/role/ScheduleofintangibleassetsTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets", "totalLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet", "http://www.fountainhealthyaging.com/role/ScheduleofintangibleassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "INVENTORY" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r58" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofinventoryTable": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofinventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r60", "r333" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.fountainhealthyaging.com/role/ScheduleofinventoryTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory", "totalLabel": "Inventory, total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet", "http://www.fountainhealthyaging.com/role/ScheduleofinventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r59" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofinventoryTable": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofinventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense", "terseLabel": "Rent expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsGross": { "auth_ref": [ "r9", "r188" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements, Gross", "terseLabel": "Leasehold improvements and equipment, net" } } }, "localname": "LeaseholdImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvement [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r51", "r98", "r150", "r174", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r281", "r285", "r286", "r295", "r331", "r332" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r39", "r98", "r174", "r295", "r333", "r354", "r368" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r53", "r98", "r174", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r281", "r285", "r286", "r295", "r331", "r332", "r333" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r14", "r15", "r16", "r26", "r27", "r98", "r174", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r281", "r285", "r286", "r295", "r331", "r332" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Non-current liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r26" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Lease Obligation", "totalLabel": "Long-term lease obligations" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r87" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r87", "r88", "r91" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r67", "r69", "r74", "r77", "r91", "r98", "r107", "r109", "r110", "r111", "r112", "r115", "r116", "r122", "r146", "r148", "r151", "r154", "r156", "r174", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r292", "r295", "r359", "r373" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Profit (loss) for the period", "verboseLabel": "Net profit (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow", "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently issued accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "negatedTotalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r146", "r148", "r151", "r154", "r156" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating profit (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r313" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total lease obligations" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r313" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r313" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Non-current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r314", "r315" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flow from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r312" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r318", "r320" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherinformationTable" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r317", "r320" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Remaining lease term for operating leases (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherinformationTable" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r308", "r310" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r308", "r310" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable": { "order": 1.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "Within 1 year" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r308", "r310" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable": { "order": 2.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "After 1 year but within 5 years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r197", "r307", "r308", "r309", "r311" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.", "label": "Lessee, Operating Lease, Disclosure [Table Text Block]", "terseLabel": "LEASES" } } }, "localname": "OperatingLeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r289" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/DescriptionofBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r10", "r11", "r12", "r52" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Others" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherpayablesandaccrualsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the nature and terms of commitment.", "label": "Other Commitments, Description", "terseLabel": "Commitments and contingencies, description" } } }, "localname": "OtherCommitmentsDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r62", "r64" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax", "terseLabel": "Foreign currency translation differences" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeOtherNetOfTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other.", "label": "Other Comprehensive Income, Other, Net of Tax", "terseLabel": "Other comprehensive income (Loss)" } } }, "localname": "OtherComprehensiveIncomeOtherNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r235", "r244" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]", "terseLabel": "PREPAYMENT" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/Prepayment" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r83" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other receivables" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherTaxExpenseBenefit": { "auth_ref": [ "r99", "r247", "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other income tax expense (benefit).", "label": "Other Tax Expense (Benefit)", "terseLabel": "Others" } } }, "localname": "OtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofstatutorytaxratesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r84" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Cash acquired from business combination" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r85" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Additions to intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r85" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Additions to leasehold improvements and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Series A preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r29", "r213" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Series A Preferred Stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Series A Preferred Stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r29", "r213" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Series A preferred Stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Series A preferred Stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r29", "r333" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Series A Preferred Stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r7", "r44", "r45" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepayment" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r67", "r69", "r74", "r86", "r98", "r107", "r115", "r116", "r146", "r148", "r151", "r154", "r156", "r174", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r279", "r282", "r283", "r287", "r288", "r292", "r295", "r362" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net profit (loss) for the period" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r48", "r190" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r191", "r390", "r391", "r392" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "LEASEHOLD IMPROVEMENT AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r47", "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Leasehold improvement and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r20", "r21", "r190", "r333", "r363", "r369" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Leasehold improvement and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r20", "r190" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of leasehold improvement and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/LeaseholdImprovementandEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r20", "r188" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivableWithImputedInterestNetAmount": { "auth_ref": [ "r303" ], "calculation": { "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The receivable or note face amount less the unamortized discount or premium.", "label": "Receivable with Imputed Interest, Net Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "ReceivableWithImputedInterestNetAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleoffutureminimumpaymentsunderlongtermnoncancelableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r236", "r325", "r326", "r328" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable", "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": { "auth_ref": [ "r27", "r306", "r319", "r321", "r322", "r324" ], "lang": { "en-us": { "role": { "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.", "label": "Related Party Transaction, Description of Transaction", "terseLabel": "Relationship, description", "verboseLabel": "Relationship, decription" } } }, "localname": "RelatedPartyTransactionDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable", "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofamountduefromrelatedpartiesTable", "http://www.fountainhealthyaging.com/role/ScheduleofamountduetorelatedpartiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.", "label": "Related Party Transaction, Other Revenues from Transactions with Related Party", "terseLabel": "Revenues from transactions with franchisees" } } }, "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofrevenueTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r236", "r325", "r328", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r323", "r324", "r326", "r329", "r330" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTIES TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/RelatedPartiesTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r35", "r218", "r242", "r333", "r367", "r383", "r385" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings (Accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAppropriatedMember": { "auth_ref": [ "r34", "r212" ], "lang": { "en-us": { "role": { "documentation": "A segregation of retained earnings which is unavailable for dividend distribution. Includes also retained earnings appropriated for loss contingencies.", "label": "Retained Earnings, Appropriated [Member]", "terseLabel": "(Accumulated Deficit) Retain Earnings Statutory Reserve" } } }, "localname": "RetainedEarningsAppropriatedMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r104", "r105", "r106", "r108", "r114", "r116", "r175", "r239", "r240", "r241", "r258", "r259", "r290", "r380", "r382" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "(Accumulated Deficit) Retain Earnings Unrestricted" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r231", "r234" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "REVENUE" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r95", "r96" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r75", "r98", "r142", "r143", "r147", "r152", "r153", "r157", "r158", "r160", "r174", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r295", "r362" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement", "http://www.fountainhealthyaging.com/role/ScheduleofrevenueTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r316", "r320" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofotherinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Common stock price per share (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r136", "r160" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Net revenue [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/RisksandUncertaintiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofaccountsreceivableTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of accounts receivable" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of other payables and accruals" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/OtherPayablesandAccrualsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]", "terseLabel": "Schedule of intangible assets" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of income tax benefits" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of statutory tax rates" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Schedule of future minimum payments under long-term non-cancelable operating leases" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r13", "r41", "r42", "r43" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r48", "r190" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "negatedLabel": "Selling and marketing expenses" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A preferred Stock" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Business Acquisition [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Share issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/DescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r94", "r103" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r28", "r29", "r30", "r97", "r98", "r119", "r120", "r121", "r123", "r125", "r129", "r130", "r131", "r174", "r198", "r203", "r204", "r205", "r209", "r210", "r213", "r214", "r215", "r216", "r217", "r295", "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r56", "r72", "r73", "r74", "r104", "r105", "r106", "r108", "r114", "r116", "r128", "r175", "r217", "r218", "r239", "r240", "r241", "r258", "r259", "r290", "r297", "r298", "r299", "r300", "r301", "r302", "r380", "r381", "r382", "r419" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r104", "r105", "r106", "r128", "r337" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r56", "r217", "r218" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Business combination under common control" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r30", "r37", "r38", "r98", "r169", "r174", "r295", "r333" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet", "http://www.fountainhealthyaging.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "EQUITY (DEFICIT)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r198", "r203", "r204", "r205", "r209", "r210" ], "calculation": { "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Share capital (750,000,000 shares of Common Stock, par value $0.00001 per share, authorized, of which 609,316,077 and 600,034,500 shares are issued and outstanding as of September 30, 2021 and December 31, 2020, respectively; and 100,000,000 shares of Series A Preferred Stock, par value $0.00001 per share, of which all 100,000,000 shares are issued and outstanding)" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r164", "r165", "r166", "r167", "r168", "r171" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r132", "r133", "r134", "r135", "r138", "r139", "r140" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Motor vehicle [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ScheduleofleaseholdimprovementandequipmentnetTable" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r118", "r125" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "- Diluted (in Shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r117", "r125" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "- Basic (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.fountainhealthyaging.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r172": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196816" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r185": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r191": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21332-112643" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r235": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r278": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r289": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123395306&loc=d3e36975-112693" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918703-209980" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919370-209981" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919784-209982" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3)(i))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r402": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r403": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r404": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r405": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r406": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r407": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r408": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r409": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r411": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r412": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r413": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r414": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r415": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r416": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r417": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "i", "Publisher": "SEC", "Section": "3", "Subsection": "10" }, "r418": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } ZIP 77 0001213900-21-059027-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-21-059027-xbrl.zip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�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�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
VG:9=E#7M>P&W.$"V7D WWHGL2$D];VJ-O.Q[P=QF'R5G U'X,4/OP1Q2/OKAC;-44_1*@%:B M)%XS25E=S0I+=5%YXB?DG*EIET4M4%L'0U'9U'/%3@IN:[HT^$(^:U")&XUNHS"@=>DDE-'@TQK! M]T5Z/)S2EP43E>. +&-*EW+I.6HB*T*R$[>(RJ:T>EWO:LE:$Z!M+]Z(G!J> M?P4;'094@KA?X5>;R939D8CG3=?WACF28D]\#U:TM-N?LZRV6O3?"+@?5M3, MFT1JWULRJDOH 3PDN^4<81TF5837KTVHQ(M$,F^[WW52TN\ AFBJ(\BKAM@3 M?U?#CD0^/]CP=RE)VZ#SDOQ&3Z*C#+,?7JZ6(XF8WG7NX(H4QFJ016VI07P/'U2*H#KQY94Q8=4*A9R"8FV M/+,GS])I1\3]ZC"A7:#]*ZFHU),-*NF&N.554ZXA =:3D^PN$U*1 M*&<9Y.1!RTTQ40Y&-NNR&<9=-$,TU7'MV@R_%RH9"5G2#Z133\87Q?^@Z3C6(K0IJCRRNDBGI MC:[%',4N7:^,".M5OX7U:BNLSH=$-]'UVHBP7O=;6*^WPM(U,U->6$/RXRV> MH*>FDE]!4>5@]N.X5+_#E:8XOA)LKPY=U8Q)):: HRZ< J ])\^+*4P%T7_]PA>@% MV +Y.A(2.\!Z8AN[3$@%8BTA0: XK*?OW F=I&I&2R:B$G"?HH$ZWJ0BTY!\ MJ&WG^>F8$O3H!(#^Z_\!4$L! A0#% @ 6$IO4W8;UIKOM@ LDL( !P M ( ! &8Q,'$P.3(Q7V9O=6YT86EN:&5A;'1H>2YH=&U0 M2P$"% ,4 " !82F]3F4*C2"T' ;)0 &P @ $IMP M9C$P<3 Y,C%E>#,Q+3%?9F]U;G1A:6XN:'1M4$L! A0#% @ 6$IO4]Q1 M?,XL!P :R0 !L ( !C[X &8Q,'$P.3(Q97@S,2TR7V9O M=6YT86EN+FAT;5!+ 0(4 Q0 ( %A*;U._9!_YZ@, 'D, ; M " ?3% !F,3!Q,#DR,65X,S(M,5]F;W5N=&%I;BYH=&U02P$"% ,4 M " !82F]3D?KG>PP$ "J# &P @ $7R@ 9C$P<3 Y M,C%E>#,R+3)?9F]U;G1A:6XN:'1M4$L! A0#% @ 6$IO4[ER9%/O#P M?:H !$ ( !7,X &9H86DM,C R,3 Y,S N>'-D4$L! A0# M% @ 6$IO4_&I#8CT#0 HJ4 !4 ( !>MX &9H86DM M,C R,3 Y,S!?8V%L+GAM;%!+ 0(4 Q0 ( %A*;U-$Z2%ZJBT /R4 @ 5 M " :'L !F:&%I+3(P,C$P.3,P7V1E9BYX;6Q02P$"% ,4 M " !82F]3X0PRXH5D NZ@0 %0 @ %^&@$ 9FAA:2TR M,#(Q,#DS,%]L86(N>&UL4$L! A0#% @ 6$IO4YRU:,6.+0 IK4" !4 M ( !-G\! &9H86DM,C R,3 Y,S!?<')E+GAM;%!+!08 .."@ * +D" #WK $ ! end